Original Article

Prevalence of Diabetes among Men and Women in China

Wenying Yang, M.D., Juming Lu, M.D., Jianping Weng, M.D., Weiping Jia, M.D., Linong Ji, M.D., Jianzhong Xiao, M.D., Ph.D., Zhongyan Shan, M.D., Jie Liu, M.D., Haoming Tian, M.D., Qiuhe Ji, M.D., Dalong Zhu, M.D., Jiapu Ge, M.D., Lixiang Lin, M.D., Li Chen, M.D., Xiaohui Guo, M.D., Zhigang Zhao, M.D., Qiang Li, M.D., Zhiguang Zhou, M.D., Guangliang Shan, M.D., Ph.D., and Jiang He, M.D., Ph.D. for the China National Diabetes and Metabolic Disorders Study Group

N Engl J Med 2010; 362:1090-1101March 25, 2010DOI: 10.1056/NEJMoa0908292

Abstract

Background

Because of the rapid change in lifestyle in China, there is concern that diabetes may become epidemic. We conducted a national study from June 2007 through May 2008 to estimate the prevalence of diabetes among Chinese adults.

Methods

A nationally representative sample of 46,239 adults, 20 years of age or older, from 14 provinces and municipalities participated in the study. After an overnight fast, participants underwent an oral glucose-tolerance test, and fasting and 2-hour glucose levels were measured to identify undiagnosed diabetes and prediabetes (i.e., impaired fasting glucose or impaired glucose tolerance). Previously diagnosed diabetes was determined on the basis of self-report.

Results

The age-standardized prevalences of total diabetes (which included both previously diagnosed diabetes and previously undiagnosed diabetes) and prediabetes were 9.7% (10.6% among men and 8.8% among women) and 15.5% (16.1% among men and 14.9% among women), respectively, accounting for 92.4 million adults with diabetes (50.2 million men and 42.2 million women) and 148.2 million adults with prediabetes (76.1 million men and 72.1 million women). The prevalence of diabetes increased with increasing age (3.2%, 11.5%, and 20.4% among persons who were 20 to 39, 40 to 59, and ≥60 years of age, respectively) and with increasing weight (4.5%, 7.6%, 12.8%, and 18.5% among persons with a body-mass index [the weight in kilograms divided by the square of the height in meters] of <18.5, 18.5 to 24.9, 25.0 to 29.9, and ≥30.0, respectively). The prevalence of diabetes was higher among urban residents than among rural residents (11.4% vs. 8.2%). The prevalence of isolated impaired glucose tolerance was higher than that of isolated impaired fasting glucose (11.0% vs. 3.2% among men and 10.9% vs. 2.2% among women).

Conclusions

These results indicate that diabetes has become a major public health problem in China and that strategies aimed at the prevention and treatment of diabetes are needed.

Media in This Article

Figure 1Age-Specific Prevalences of Diabetes and Prediabetes among Chinese Adults 20 Years of Age or Older.
Figure 2Prevalences of Diabetes and Prediabetes and Absolute Numbers of Cases among Chinese Adults 20 Years of Age or Older, According to Urban or Rural Residence.
Article

Cardiovascular disease has become the leading cause of death in China, a development that has followed rapid economic growth, an increase in life expectancy, and changes in lifestyle.1 Diabetes is a major risk factor for cardiovascular disease, and the prevalence of diabetes is high and is increasing in China.2-4 A national survey conducted in 1994, involving 224,251 Chinese residents, 25 to 64 years of age, from 19 provinces, showed that the prevalences of diabetes and impaired glucose tolerance were 2.5% and 3.2%, respectively.2 These estimates were higher by a factor of approximately 3 than those reported in 1980.3 In a cross-sectional study in 2000–2001 involving a nationally representative sample of 15,540 adults, 35 to 74 years of age, the prevalences of diabetes and impaired fasting glucose were 5.5% and 7.3%, respectively.4 Although these studies have documented a marked increase in the prevalence of diabetes in China, they cannot be compared directly, owing to methodologic differences in sampling and to differences in the criteria used to define diabetes.2-4 Furthermore, the prevalences of diabetes and prediabetes were probably underestimated in these studies because 2-hour oral glucose-tolerance tests were not performed in all participants. It has been suggested that isolated hyperglycemia 2 hours after glucose loading is common among Asian patients with diabetes.5 For example, in the Shanghai Diabetes Study, 48.6% of patients with newly diagnosed diabetes had isolated hyperglycemia 2 hours after glucose loading, and 75.0% of those with prediabetes had isolated impaired glucose tolerance.6

The China National Diabetes and Metabolic Disorders Study, conducted from June 2007 through May 2008, was a cross-sectional study designed to provide current and reliable data on the prevalences of diabetes and associated metabolic risk factors in the adult population in China.

Methods

Study Participants

We used a multistage, stratified sampling method to select a nationally representative sample of persons 20 years of age or older in the general population. The sampling process was stratified according to geographic region (northeast, north, east, south central, northwest, and southwest China), degree of urbanization (large cities [Beijing, Shanghai, and provincial capitals], midsize cities, county seats, and rural townships), and economic development status (as assessed on the basis of the gross domestic product [GDP] for each province). The first two stages of sampling, in which provinces were selected from geographic regions and cities and counties were selected from provinces, were not random. In the next two stages (the stage in which city districts were selected from cities and rural townships from counties and the stage in which street districts were selected from city districts and rural villages from townships), the sampling was random (see Figure 1 in the Supplementary Appendix, available with the full text of this article at NEJM.org). This multistage, stratified sampling process resulted in an oversampling of urban residents. In total, 152 urban street districts and 112 rural villages were selected. In the final stage of sampling, the sample was stratified according to the sex and age distribution in China, on the basis of Chinese population data from 2006.7 Only persons who had lived in their current residence for 5 years or longer were eligible to participate.

A total of 54,240 people were selected and invited to participate in the study; 47,325 persons (18,976 men and 28,349 women) completed the study. The overall response rate was 87.3%: 81.0% for men and 92.0% for women; 88.1% of those who lived in urban areas and 82.7% of those who lived in rural areas responded. After the exclusion of 538 persons for whom demographic information was missing and 548 for whom data on fasting or 2-hour plasma glucose levels were missing, 46,239 adults were included in the final analysis.

The institutional review board or ethics committee at each participating institution approved the study protocol. Written informed consent was obtained from each participant before data collection.

Data Collection

A standard questionnaire was administered by trained staff to obtain information on demographic characteristics, personal and family medical history, and lifestyle risk factors.8 The interview included questions related to the diagnosis and treatment of diabetes, hypertension, dyslipidemia, and cardiovascular events. Cigarette smoking was defined as having smoked at least 100 cigarettes in one's lifetime. Information was obtained on the amount and type of alcohol that was consumed during the previous year, and alcohol drinking was defined as the consumption of at least 30 g of alcohol per week for 1 year or more. Regular leisure-time physical activity was defined as participation in moderate or vigorous activity for 30 minutes or more per day at least 3 days a week. Socioeconomic status, educational level, occupation, and income were also recorded. The economic development of provinces or municipalities was defined on the basis of the GDP per capita in 2006. Blood pressure, body weight, height, and waist circumference were measured with the use of standard methods, as described previously.2

All study investigators and staff members successfully completed a training program that familiarized them with both the aims of the study and the specific tools and methods used. At the training sessions, interviewers were given detailed instructions concerning the administration of the study questionnaire. Clinical staff members were trained to measure blood pressure and obtain anthropometric measurements and blood specimens according to a standard protocol.8

Oral Glucose-Tolerance Test

Participants were instructed to maintain their usual physical activity and diet for at least 3 days before the oral glucose-tolerance test. After at least 10 hours of overnight fasting, a venous blood specimen was collected in a vacuum tube containing sodium fluoride, for the measurement of plasma glucose. Participants with no history of diabetes were given a standard 75-g glucose solution, whereas for safety reasons, participants with a self-reported history of diabetes were given a steamed bun that contained approximately 80 g of complex carbohydrates. Blood samples were drawn at 0, 30, and 120 minutes after the glucose or carbohydrate load to measure glucose concentrations. Plasma glucose was measured with the use of a hexokinase enzymatic method, and serum cholesterol and triglyceride levels were assessed enzymatically with the use of commercially available reagents, at the clinical biochemical laboratories in each province. All the study laboratories successfully completed a standardization and certification program.

Study-Outcome Definitions

The 1999 World Health Organization diagnostic criteria were used to diagnose diabetes.9 Results of plasma glucose testing were categorized as follows: isolated impaired fasting glucose (fasting glucose level, ≥110 mg per deciliter [6.1 mmol per liter] and <126 mg per deciliter [7.0 mmol per liter), and 2-hour glucose level in the glucose-tolerance test, <140 mg per deciliter [7.8 mmol per liter]), isolated impaired glucose tolerance (fasting glucose level, <110 mg per deciliter, and 2-hour glucose level, ≥140 and <200 mg per deciliter [11.1 mmol per liter]), combined impaired fasting glucose and impaired glucose tolerance (fasting glucose level, ≥110 and <126 mg per deciliter, and 2-hour glucose level, ≥140 and <200 mg per deciliter), and undiagnosed diabetes (fasting glucose level, ≥126 mg per deciliter, 2-hour glucose level, ≥200 mg per deciliter, or both). Previously diagnosed diabetes was identified by a positive response from the participant to the question, “Has a doctor ever told you that you have diabetes?” Among participants with previously diagnosed diabetes, 81.2% were using insulin or oral hypoglycemic agents and 14.9% were using lifestyle intervention alone (diet, regular exercise, or both). Total diabetes included both previously diagnosed diabetes and previously undiagnosed diabetes. Prediabetes was defined as either impaired fasting glucose or impaired glucose tolerance.

Statistical Analysis

Our study was designed to provide accurate estimates of the prevalence of diabetes according to age, sex, urban or rural residence, and level of economic development in the general Chinese population of persons 20 years of age or older. Sample sizes were estimated to meet generally recommended requirements for precision in a complex survey design.10 All calculations were weighted to represent the total population of Chinese adults (20 years of age or older) on the basis of Chinese population data from 2006 and the study sampling scheme, and were corrected for several features of the survey, including oversampling for female and urban residents, nonresponse, highly developed economic regions, and other demographic or geographic differences between the sample and the total population.

Mean values for lifestyle and metabolic factors were determined according to sex and plasma glucose categories. Prevalence estimates for diabetes and prediabetes were calculated for the overall population and for subgroups according to age, sex, and other variables. Age- and sex-standardized prevalences were calculated by the direct method with the use of data on the population distribution in China in 2006.7 Estimated numbers of persons with diabetes and prediabetes were calculated from subgroup-specific prevalences according to age, sex, geographic region, urban or rural residence, and level of economic development and from data on the size of the population in China in 2006. A multinomial logit analysis was used to examine the association of demographic, lifestyle, and metabolic factors with the odds of diabetes and prediabetes. With the use of backward elimination, only covariables that were significant (P<0.05) were retained in the final model. Standard errors were calculated with the use of a technique that was appropriate to the complex survey design. All P values are two-tailed and have not been adjusted for multiple testing. All statistical analyses were conducted with the use of SUDAAN software, version 10 (Research Triangle Institute).

Results

Prevalences of Diabetes and Prediabetes

The prevalences of isolated impaired fasting glucose, isolated impaired glucose tolerance, combined impaired fasting glucose and impaired glucose tolerance, previously undiagnosed diabetes, and previously diagnosed diabetes were 3.2%, 11.0%, 1.9%, 6.5%, and 4.1% among men and 2.2%, 10.9%, 1.7%, 5.2%, and 3.5% among women, respectively (Table 1Table 1Characteristics of Study Participants According to Plasma Glucose Categories and Sex.). The prevalence of undiagnosed diabetes in which the 2-hour plasma glucose level in an oral glucose-tolerance test was 200 mg per deciliter or more but the fasting glucose level was less than 126 mg per deciliter was 2.9% among men and 2.6% among women. In other words, 46.6% of the participants with undiagnosed diabetes (44.1% of the men and 50.2% of the women) had isolated increased 2-hour plasma glucose levels after an oral glucose-tolerance test. In the case of approximately 61.3% of the men with diabetes and 59.8% of the women with diabetes, the diabetes had not previously been diagnosed. In general, patients with previously diagnosed diabetes had higher fasting plasma glucose levels and higher 2-hour plasma glucose levels in an oral glucose-tolerance test than did those with undiagnosed diabetes. In addition, patients with previously diagnosed diabetes, as compared with those with undiagnosed diabetes, were older, more likely to have a family history of diabetes, more likely to participate in leisure-time physical activity, less likely to smoke cigarettes, and less likely to be obese. A total of 70.7% of the participants with prediabetes (68.3% of the men and 73.6% of the women) had isolated impaired glucose tolerance, and participants with isolated impaired glucose tolerance were slightly older than those who had isolated impaired fasting glucose. In addition, women with isolated impaired glucose tolerance had a higher body-mass index, higher systolic blood pressure, and higher serum triglyceride levels than did women with isolated impaired fasting glucose.

The overall prevalences of total diabetes (previously diagnosed plus previously undiagnosed diabetes) and prediabetes were 9.7% and 15.5%, respectively. The age-specific prevalences of diabetes and prediabetes increased significantly with increasing age (P<0.001 for both comparisons) (Figure 1Figure 1Age-Specific Prevalences of Diabetes and Prediabetes among Chinese Adults 20 Years of Age or Older.). The age-standardized prevalence of diabetes was significantly higher among men than among women (P<0.001), but the age-standardized prevalence of prediabetes did not differ significantly according to sex (P=0.08). The age-standardized prevalence of diabetes was significantly higher among urban residents than among rural residents (11.4% vs. 8.2%, P<0.001) (Figure 2Figure 2Prevalences of Diabetes and Prediabetes and Absolute Numbers of Cases among Chinese Adults 20 Years of Age or Older, According to Urban or Rural Residence.); however, the age-standardized prevalence of prediabetes was slightly lower among urban residents than among rural residents (14.9% vs. 16.0%, P=0.06).

Metabolic Risk Factors

The age-adjusted mean fasting glucose level, body-mass index, waist circumference, serum triglyceride level, and systolic blood pressure were significantly higher in men than in women, whereas the high-density lipoprotein (HDL) cholesterol level was lower in men than in women (Table 2Table 2Age- and Sex-Standardized Prevalences of Diabetes and Prediabetes and Mean Values of Metabolic Risk Factors in the Overall Cohort and in Subgroups.). The sex-adjusted fasting glucose level, 2-hour glucose level in an oral glucose-tolerance test, body-mass index, waist circumference, HDL cholesterol level, triglyceride level, and systolic blood pressure all increased significantly with increasing age. The age- and sex-adjusted prevalences of diabetes and prediabetes, as well as the mean fasting glucose level, 2-hour glucose level in the oral glucose-tolerance test, waist circumference, serum triglyceride level, and systolic blood pressure, increased significantly, whereas the HDL cholesterol level decreased, with increasing body-mass index.

Economic Development and Urbanization

In the economically developed regions, the age- and sex-adjusted prevalence of diabetes did not differ significantly between urban and rural residents, whereas the prevalence of prediabetes was higher among rural residents. In the intermediately developed and underdeveloped regions, the prevalence of diabetes and levels of metabolic risk factors were higher among urban residents than among rural residents.

In 2007–2008, it was estimated that among adults 20 years of age or older in China, there were 92.4 million persons with diabetes (50.2 million men and 42.2 million women) and 148.2 million persons with prediabetes (76.1 million men and 72.1 million women). An estimated 49.3 million persons with diabetes lived in urban areas, and 43.1 million in rural areas (Figure 2); an estimated 64.7 million persons with prediabetes lived in urban areas, and 83.5 million in rural areas.

Multivariable Risk Assessment

In the multivariable, multinomial, logit models, male sex, older age, a family history of diabetes, overweight, obesity, central obesity, increased heart rate, elevated systolic blood pressure, elevated serum triglyceride level, educational level below college, and urban residence were all significantly associated with an increased risk of diabetes (Table 3Table 3Multivariable-Adjusted Odds Ratios for Diabetes and Prediabetes.). In addition, older age, a family history of diabetes, overweight, obesity, central obesity, increased heart rate, elevated systolic blood pressure, elevated serum triglyceride level, and educational level below college were significantly associated with an increased risk of prediabetes, whereas there was a marginally significant association between urban residence and a decreased risk of prediabetes.

Discussion

Our results indicate that diabetes has reached epidemic proportions in the general adult population in China. Overall, 92.4 million adults 20 years of age or older (9.7% of the adult population) have diabetes, and in 60.7% of these cases, the diabetes is undiagnosed. In addition, 148.2 million adults (15.5%) have prediabetes, which is an important risk factor for the development of overt diabetes and cardiovascular disease.11,12 These findings, which are based on a large population-based study involving a nationally representative sample of Chinese adults, should provide an accurate estimate of the diabetes and prediabetes burden in China. In addition, the diagnosis of diabetes was established on the basis of both fasting plasma glucose levels and 2-hour plasma glucose levels in an oral glucose-tolerance test, and these measurements were obtained with the use of stringent quality-control procedures.

Diabetes increases the risk of microvascular and macrovascular complications and premature death in the general population and results in a huge economic burden for society.13-17 Randomized clinical trials have shown that interventions involving diet and exercise reduce the risk of diabetes among people with prediabetes.18-20 Public health measures should be undertaken to mitigate the consequences of new cases of diabetes.

Several previous national or regional studies have documented a rapid increase in the prevalence of diabetes in the Chinese adult population.2-4,6,21 However, in those studies, oral glucose-tolerance tests were not performed in the entire study population or in a random sample2-4; therefore, the true prevalence of undiagnosed diabetes may have been underestimated. In the present study, 46.6% of the cases of undiagnosed diabetes and 70.7% of the cases of prediabetes met the criteria for elevated 2-hour plasma glucose levels in an oral glucose-tolerance test but not the criteria for elevated fasting glucose levels. Qiao and colleagues found that in a pooled analysis of Asian cohorts, more than half the subjects with diabetes had isolated hyperglycemia after glucose loading and three quarters of the subjects with prediabetes had isolated impaired glucose tolerance.5 Even accounting for differences in diagnostic criteria, our study documents a large increase in the prevalences of previously diagnosed diabetes, previously undiagnosed diabetes, and prediabetes. The aging of the population, urbanization, nutritional changes, and decreasing levels of physical activity, with a consequent epidemic of obesity, have probably contributed to the rapid increase in the diabetes burden in the Chinese population.21-23 Future studies are needed to examine the relative contributions of individual risk factors to the increased prevalence of diabetes in the Chinese population.

A higher prevalence of diabetes among urban residents than among rural residents has been observed in developing countries throughout the world.2-4,16,17,24,25 Urbanization is associated with changes in lifestyle that lead to physical inactivity, an unhealthful diet, and obesity, all of which have been implicated as contributing factors in the development of diabetes.26-28 In our study, both overall obesity and central obesity were strongly associated with increased prevalences of diabetes and prediabetes. In the analysis stratified according to the level of economic development, the prevalence of diabetes was similar between urban residents and rural residents in economically developed regions but differed between these groups in intermediately developed and underdeveloped regions. Our analysis suggests that the level of economic development and associated lifestyle and diet may explain the differences in the prevalence of diabetes between persons who live in urban settings and those who live in rural areas.

Like previous studies,29,30 our study showed a significant inverse association between educational level and the prevalence of diabetes. Educational level is a good indicator of socioeconomic status, and a higher educational level has been associated with lower levels of cardiovascular risk factors, such as obesity, dyslipidemia, and hypertension.31,32

Our study has several limitations. First, women and urban residents were oversampled, and there was a lower response rate among men than among women. We took these issues into account when we calculated statistical weights. However, the response rate was higher than 80% among men, and potential selection bias due to nonresponse should be minimal. Second, dietary intake and work-related physical activity were not assessed in our study. Therefore, we were not able to determine the association between these factors and the prevalence of diabetes. Third, to ensure comparability across studies, we used the World Health Organization criteria to define diabetes and prediabetes in our study. The relationship of glucose categories to the risk of microvascular and macrovascular diseases, however, has not been extensively examined in the Chinese population.20,33

In summary, our results show that diabetes and prediabetes are highly prevalent in the general adult population in China. Given its large population, China may bear a higher diabetes-related burden than any other country.16,17 More troublesome is the finding that the majority of cases of diabetes are undiagnosed. These results indicate that diabetes has become a major public health challenge in China and underscore the need for national strategies aimed at the prevention, detection, and treatment of diabetes in the general Chinese population.

Supported by grants from the Chinese Medical Association Foundation and Chinese Diabetes Society.

No potential conflict of interest relevant to this article was reported.

Source Information

From China–Japan Friendship Hospital, Beijing (W.Y., J.X.); Chinese People's Liberation Army General Hospital, Beijing (J. Lu); Sun Yat-sen University Third Hospital, Guangzhou (J.W.); Shanghai Jiaotong University Affiliated Sixth People's Hospital, Shanghai (W.J.); Peking University People's Hospital, Beijing (L.J.); First Affiliated Hospital, Chinese Medical University, Liaoling (Z.S.); Shanxi Province People's Hospital, Taiyuan, Shaanxi (J. Liu); West China Hospital, Sichuan University, Chengdu, Sichuan (H.T.); Xijing Hospital, Fourth Military Medical University, Xi'an, Shaanxi (Q.J.); Affiliated Drum Tower Hospital of Nanjing University Medical School, Nanjing, Jiangsu (D.Z.); Xinjiang Uygur Autonomous Region's Hospital, Urmqi, Xinjiang (J.G.); Fujian Provincial Hospital, Fuzhou, Fujiang (L.L.); Qilu Hospital, Qilu Hospital of Shandong University, Jinan, Shandong (L.C.); Peking University First Hospital, Beijing (X.G.); Henan Province People's Hospital, Zhengzhou, Henan (Z. Zhao); Second Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang (Q.L.); Xiangya Second Hospital, Changsha, Hunan (Z. Zhou); and Peking Union Medical College, Beijing (G.S.) — all in China; and Tulane University School of Public Health and Tropical Medicine, New Orleans (J.H.).

Address reprint requests to Dr. Yang at the Department of Endocrinology, China–Japan Friendship Hospital, Beijing 100029, China, or at .

The members of the China National Diabetes and Metabolic Disorders Study group are listed in the Supplementary Appendix, available with the full text of this article at NEJM.org.

References

References

  1. 1

    He J, Gu D, Wu X, et al. Major causes of death among men and women in China. N Engl J Med 2005;353:1124-1134
    Free Full Text | Web of Science | Medline

  2. 2

    Pan XR, Yang WY, Li GW, Liu J. Prevalence of diabetes and its risk factors in China, 1994. Diabetes Care 1997;20:1664-1669
    CrossRef | Web of Science | Medline

  3. 3

    National Diabetes Research Group. Diabetes mellitus survey of 300,000 in fourteen provinces and cities of China. Chin Med J 1981;20:678-681

  4. 4

    Gu D, Reynolds K, Duan X, et al. Prevalence of diabetes and impaired fasting glucose in the Chinese adult population: International Collaborative Study of Cardiovascular Disease in Asia (InterASIA). Diabetologia 2003;46:1190-1198
    CrossRef | Web of Science | Medline

  5. 5

    Qiao Q, Nakagami T, Tuomilehto J, et al. Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts. Diabetologia 2000;43:1470-1475
    CrossRef | Web of Science | Medline

  6. 6

    Jia WP, Pang C, Chen L, et al. Epidemiological characteristics of diabetes mellitus and impaired glucose regulation in a Chinese adult population: the Shanghai Diabetes Studies, a cross-sectional 3-year follow-up study in Shanghai urban communities. Diabetologia 2007;50:286-292
    CrossRef | Web of Science | Medline

  7. 7

    National Bureau of Statistics of China. China statistical yearbook — 2006. Beijing: China Statistics Press, 2006. (Accessed February 26, 2010, at http://www.stats.gov.cn/tjsj/ndsj/2006/indexeh.htm.)

  8. 8

    Luepker RV, Evans A, McKeigue P, Reddy KS. Cardiovascular survey methods. 3rd ed. Geneva: World Health Organization, 2004.

  9. 9

    Department of Noncommunicable Disease Surveillance. Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1. Diagnosis and classification of diabetes mellitus. Geneva: World Health Organization, 1999. (Accessed February 26, 2010, at http://www.staff.ncl.ac.uk/philip.home/who_dmg.pdf.)

  10. 10

    Plan and operation of the Third National Health and Nutrition Examination Survey, 1988-94. Series 1: programs and collection procedures. Vital Health Stat 1 1994;32:1-407
    Medline

  11. 11

    Schmidt MI, Duncan BB, Bang H, et al. Identifying individuals at high risk for diabetes: the Atherosclerosis Risk in Communities study. Diabetes Care 2005;28:2013-2018
    CrossRef | Web of Science | Medline

  12. 12

    Levitzky YS, Pencina MJ, D'Agostino RB, et al. Impact of impaired fasting glucose on cardiovascular disease: the Framingham Heart Study. J Am Coll Cardiol 2008;51:264-270
    CrossRef | Web of Science | Medline

  13. 13

    Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-234
    Free Full Text | Web of Science | Medline

  14. 14

    Schramm TK, Gislason GH, Kober L, et al. Diabetes patients requiring glucose-lowering therapy and nondiabetics with a prior myocardial infarction carry the same cardiovascular risk: a population study of 3.3 million people. Circulation 2008;117:1945-1954
    CrossRef | Web of Science | Medline

  15. 15

    Brancati FL, Whelton PK, Randall BL, Neaton JD, Stamler J, Klag MJ. Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT: Multiple Risk Factor Intervention Trial. JAMA 1997;278:2069-2074
    CrossRef | Web of Science | Medline

  16. 16

    Wild S, Roglic G, Green A, Sicree R, King H. Global prevalence of diabetes: estimates for the year 2000 and projections for 2030. Diabetes Care 2004;27:1047-1053
    CrossRef | Web of Science | Medline

  17. 17

    Diabetes atlas. 3rd ed. Brussels: International Diabetes Federation, 2008. (Accessed February 26, 2010, at http://www.eatlas.idf.org/index-2.html.)

  18. 18

    Tuomilehto J, Lindstrom J, Eriksson JG, et al. Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance. N Engl J Med 2001;344:1343-1350
    Free Full Text | Web of Science | Medline

  19. 19

    Diabetes Prevention Program Research Group. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403
    Free Full Text | Web of Science | Medline

  20. 20

    Li G, Zhang P, Wang J, et al. The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study. Lancet 2008;371:1783-1789
    CrossRef | Web of Science | Medline

  21. 21

    Li G, Hu Y, Pan X. Prevalence and incidence of NIDDM in Daqing City. Chin Med J (Engl) 1996;109:599-602
    Web of Science | Medline

  22. 22

    Leeder S, Raymond S, Greenberg H, Liu H, Esson K. A race against time: the challenge of cardiovascular disease in developing economies. New York: Columbia University, 2004.

  23. 23

    Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet 2008;372:1697-1705
    CrossRef | Web of Science | Medline

  24. 24

    Wang Y, Mi J, Shan XY, Wang QJ, Ge KY. Is China facing an obesity epidemic and the consequences? The trends in obesity and chronic disease in China. Int J Obes (Lond) 2007;31:177-188
    CrossRef | Web of Science | Medline

  25. 25

    Singh RB, Bajaj S, Niaz MA, Rastogi SS, Moshiri M. Prevalence of type 2 diabetes mellitus and risk of hypertension and coronary artery disease in rural and urban population with low rates of obesity. Int J Cardiol 1998;66:65-72
    CrossRef | Web of Science | Medline

  26. 26

    Reynolds K, Gu D, Whelton PK, et al. Prevalence and risk factors of overweight and obesity in China. Obesity (Silver Spring) 2007;15:10-18
    CrossRef | Web of Science | Medline

  27. 27

    Muntner P, Gu D, Wildman RP, et al. Prevalence of physical activity among Chinese adults: results from the International Collaborative Study of Cardiovascular Disease in Asia. Am J Public Health 2005;95:1631-1636
    CrossRef | Web of Science | Medline

  28. 28

    Li LM, Rao KQ, Kong LZ, et al. A description on the Chinese national nutrition and health survey in 2002. Zhonghua Liu Xing Bing Xue Za Zhi 2005;26:478-484
    Medline

  29. 29

    Borrell LN, Dallo FJ, White K. Education and diabetes in a racially and ethnically diverse population. Am J Public Health 2006;96:1637-1642
    CrossRef | Web of Science | Medline

  30. 30

    Ko GTC, Chan JCN, Yeung VT, Chow CC, Tsang LW, Cockram CS. A low socio-economic status is an additional risk factor for glucose intolerance in high risk Hong Kong Chinese. Eur J Epidemiol 2001;17:289-295
    CrossRef | Web of Science | Medline

  31. 31

    Seeman T, Merkin SS, Crimmins E, Koretz B, Charette S, Karlamangla A. Education, income and ethnic differences in cumulative biological risk profiles in a national sample of US adults: NHANES III (1988-1994). Soc Sci Med 2008;66:72-87
    CrossRef | Web of Science | Medline

  32. 32

    Yan LL, Liu K, Daviglus ML, et al. Education, 15-year risk factor progression, and coronary artery calcium in young adulthood and early middle age: the Coronary Artery Risk Development in Young Adults study. JAMA 2006;295:1793-1800
    CrossRef | Web of Science | Medline

  33. 33

    Chan JC, Malik V, Jia W, et al. Diabetes in Asia: epidemiology, risk factors, and pathophysiology. JAMA 2009;301:2129-2140
    CrossRef | Web of Science | Medline

Citing Articles (317)

Citing Articles

  1. 1

    Si Li, Chen-Gang Guo, Lu Chen, Xiao-Yang Yin, Yi-Xin Wu, Liu-Yin Fan, Hui-Zhi Fan, Cheng-Xi Cao. (2013) Impact of glutathione-HbA1c on HbA1c measurement in diabetes diagnosis via array isoelectric focusing, liquid chromatography, mass spectrometry and ELISA. Talanta 115, 323-328

  2. 2

    Qing-guo Lü, Nan-wei Tong. (2013) Interpretation of Chinese Society of Endocrinology consensus statement on hyperglycemia management target in adult inpatients in China. Journal of Diabetesn/a-n/a

  3. 3

    Rose Z.W. Ting, Eric S.H. Lau, Risa Ozaki, Winnie W.Y. Lau, Alice P.S. Kong, Andrea O.Y. Luk, Chun-Chung Chow, Ronald C.W. Ma, Yun-Kwok Wing, Juliana C.N. Chan, Wing-yee So. (2013) High risk for cardiovascular disease in Chinese type 2 diabetic patients with major depression—A 7-year prospective analysis of the Hong Kong DiabetesRegistry. Journal of Affective Disorders 149:1-3, 129-135

  4. 4

    Huixia Shen, Helen Edwards, Mary Courtney, Jan McDowell, Juan Wei. (2013) Barriers and facilitators to diabetes self-management: Perspectives of older community dwellers and health professionals in China. International Journal of Nursing Practicen/a-n/a

  5. 5

    Karen Eggleston, Jean C. Oi, Scott Rozelle, Ang Sun, Andrew Walder, Xueguang Zhou. (2013) Will Demographic Change Slow China's Rise?. The Journal of Asian Studies1-14

  6. 6

    Zhengpei Zeng, Jin-Kui Yang, Nanwei Tong, Shengli Yan, Xiling Zhang, Yan Gong, Hans-Juergen Woerle. (2013) Efficacy and safety of linagliptin added to metformin and sulphonylurea in Chinese patients with type 2 diabetes: a sub-analysis of data from a randomised clinical trial. Current Medical Research and Opinion1-9

  7. 7

    Chang-Sheng Sheng, Ming Liu, Jun Zou, Qi-Fang Huang, Yan Li, Ji-Guang Wang. (2013) Albuminuria in relation to the single and combined effects of systolic and diastolic blood pressure in Chinese. Blood Pressure 22:3, 158-164

  8. 8

    Xi Chen, Lei Liu, Wentao He, Yu Lu, Delin Ma, Tingting Du, Qian Liu, Cai Chen, Xuefeng Yu. (2013) Association of the ADRA2A polymorphisms with the risk of type 2 diabetes: A meta-analysis. Clinical Biochemistry 46:9, 722-726

  9. 9

    W. S. Yang, X. O. Shu, J. Gao, H. L. Li, H. Cai, G. Yang, B. T. Ji, N. Rothman, Y. T. Gao, W. Zheng, Y. B. Xiang. (2013) Prospective evaluation of type 2 diabetes mellitus on the risk of primary liver cancer in Chinese men and women. Annals of Oncology 24:6, 1679-1685

  10. 10

    Shengli Wu, Fengshou Yi, Chao Zhou, Mintao Zhang, Yujing Zhu, Yilihamu Tuniyazi, Lijuan Huang, Xuefang Huang, Fugang Wang, Yufang Bi, Guang Ning. (2013) HbA1c and the diagnosis of diabetes and prediabetes in a middle-aged and elderly Han population from northwest China. Journal of Diabetesn/a-n/a

  11. 11

    Mingming Gao, Yue Tong, Wen Li, Xiangdong Gao, Wenbing Yao. (2013) Improving the anti-diabetic activity of GLP-1 by fusion with globular adiponectin. Artificial Cells, Nanomedicine, and Biotechnology 41:3, 159-164

  12. 12

    Xiao Yang, Chunyan Yi, Xinhui Liu, Qunying Guo, Rui Yang, Peiyi Cao, Jiangxiong Lin, Haiping Mao, Xueqing Yu. (2013) Clinical outcome and risk factors for mortality in Chinese patients with diabetes on peritoneal dialysis: A 5-year clinical cohort study. Diabetes Research and Clinical Practice 100:3, 354-361

  13. 13

    Jian Zhou, Hong Li, Xiuzhen Zhang, Yongde Peng, Yifei Mo, Yuqian Bao, Weiping Jia. (2013) Nateglinide and Acarbose Are Comparably Effective Reducers of Postprandial Glycemic Excursions in Chinese Antihyperglycemic Agent–Naive Subjects with Type 2 Diabetes. Diabetes Technology & Therapeutics 15:6, 481-488

  14. 14

    Guang Yang, Chunlin Li, Yanping Gong, Jian Li, Xiaoling Cheng, Hui Tian. (2013) A Prospective, Randomized, Open-Label Study Comparing the Efficacy and Safety of Preprandial and Prandial Insulin in Combination with Acarbose in Elderly, Insulin-Requiring Patients with Type 2 Diabetes Mellitus. Diabetes Technology & Therapeutics 15:6, 513-519

  15. 15

    Hui Huang, Guicheng Peng, Maohuan Lin, Kun Zhang, Yifang Wang, Yu Yang, Zhiyi Zuo, Renhua Chen, Jingfeng Wang. (2013) The Diagnostic Threshold of HbA1c and Impact of its Use on Diabetes Prevalence--A Population-Based Survey of 6,898 Han Participants from Southern China. Preventive Medicine

  16. 16

    Zhan Zhang, Zhen-Zhen Sun, Xue Xiao, Shixin Zhou, Xi-Chen Wang, Jun Gu, Liang-Lin Qiu, Xu-Hui Zhang, Qiujin Xu, Binghui Zhen, Xinru Wang, Shou-Lin Wang. (2013) Mechanism of BDE209-induced impaired glucose homeostasis based on gene microarray analysis of adult rat liver. Archives of Toxicology

  17. 17

    (2013) Screening of patients with tuberculosis for diabetes mellitus in India. Tropical Medicine & International Health 18:5, 636-645

  18. 18

    X. L. Tong, S. T. Wu, F. M. Lian, M. Zhao, S. P. Zhou, X. Y. Chen, B. Yu, Z. Zhen, L. W. Qi, P. Li, C. Z. Wang, H. Sun, C. S. Yuan. (2013) The safety and effectiveness of TM81, a Chinese herbal medicine, in the treatment of type 2 diabetes: a randomized double-blind placebo-controlled trial. Diabetes, Obesity and Metabolism 15:5, 448-454

  19. 19

    H. Zhang, W. Xu, A. K. Dahl, Z. Xu, H.-X. Wang, X. Qi. (2013) Relation of socio-economic status to impaired fasting glucose and Type 2 diabetes: findings based on a large population-based cross-sectional study in Tianjin, China. Diabetic Medicine 30:5, e157-e162

  20. 20

    Yang Gao, Min-fei Yang, Ya-ping Su, Hui-min Jiang, Xiao-juan You, Yin-jing Yang, Hai-long Zhang. (2013) Ginsenoside Re reduces insulin resistance through activation of PPAR-γ pathway and inhibition of TNF-α production. Journal of Ethnopharmacology 147:2, 509-516

  21. 21

    Hui Zuo, Zumin Shi, Baojun Yuan, Yue Dai, Xiaoqun Pan, Gaolin Wu, Akhtar Hussain. (2013) Dietary patterns are associated with insulin resistance in Chinese adults without known diabetes. British Journal of Nutrition 109:09, 1662-1669

  22. 22

    Lei Wu, Chao Yu, Han Jiang, Jun Tang, He-lang Huang, Jing Gao, Xin Zhang. (2013) Diabetes Mellitus and the Occurrence of Colorectal Cancer: An Updated Meta-Analysis of Cohort Studies. Diabetes Technology & Therapeutics 15:5, 419-427

  23. 23

    Hui-yan Zhang, Jian-yong Wang, Gui-shuang Ying, Li-ping Shen, Zhe Zhang. (2013) Serum lipids and other risk factors for diabetic retinopathy in Chinese type 2 diabetic patients. Journal of Zhejiang University SCIENCE B 14:5, 392-399

  24. 24

    Liyong Yang, Ximei Shen, Sunjie Yan, Xin Yuan, Juanjuan Lu, Wenfeng Wei. (2013) HbA1c in the diagnosis of diabetes and abnormal glucose tolerance in patients with Graves’ hyperthyroidism. Diabetes Research and Clinical Practice

  25. 25

    Lizhu Chen, Xiaolu Chen, Rongjing Ding, Qiuting Shi, Dayi Hu. (2013) Evaluation of EZSCAN as a screening tool for impaired glucose metabolism. Diabetes Research and Clinical Practice 100:2, 210-214

  26. 26

    Xin Kang, Chun Wang, Lifang Lv, Dawei Chen, Yanzhi Yang, Guanjian Liu, Wen Hu, Lihong Chen, Liping He, Xiujun Li, Haoming Tian, Weiping Jia, Xingwu Ran. (2013) Effects of Different Proportion of Carbohydrate in Breakfast on Postprandial Glucose Excursion in Normal Glucose Tolerance and Impaired Glucose Regulation Subjects. Diabetes Technology & Therapeutics130417090129008

  27. 27

    Xin Mou, Di-yi Zhou, Wen-hong Liu, Dan-yang Zhou, Ying-hui Liu, Yong-bin Hu, Cheng-min Shou, Jia-wei Chen, Jin-xi Zhao, Guo-ling Ma. (2013) Study on the relationship between Chinese medicine constitutive susceptibility and diversity of syndrome in diabetic nephropathy. Chinese Journal of Integrative Medicine

  28. 28

    Li Wang, Juanjuan Zhang, Bokai Wang, Yuwen Zhang, Jie Hong, Yifei Zhang, Weiqing Wang, Weiqiong Gu. (2013) New evidence for an association between liver enzymes and pancreatic islet β-cell dysfunction in young obese patients. Endocrine

  29. 29

    Trefor Higgins. (2013) HbA1c for screening and diagnosis of diabetes mellitus. Endocrine 43:2, 266-273

  30. 30

    Mingming Gao, Yue Tong, Xiangdong Gao, Wenbing Yao. (2013) A mutated glucagon-like peptide-1 with improved glucose-lowering activity in diabetic mice. Journal of Pharmacy and Pharmacology 65:4, 539-546

  31. 31

    Shuo Lin, Li Hu, Xiaofeng Li, Yanming Chen, Haixia Xu, Shengqing He, Zhuozhuo Ren, Xixiang Tang, Yawei Qiu, Jing Xu, Panwei Mu, Longyi Zeng. (2013) Glycated haemoglobin A 1 c for diagnosing diabetes in Chinese subjects over 50 years old: a community-based cross-sectional study. Clinical Endocrinologyn/a-n/a

  32. 32

    Giuseppe Penno, Anna Solini, Enzo Bonora, Cecilia Fondelli, Emanuela Orsi, Gianpaolo Zerbini, Roberto Trevisan, Monica Vedovato, Gabriella Gruden, Luigi Laviola, Antonio Nicolucci, Giuseppe Pugliese, . (2013) Gender differences in cardiovascular disease risk factors, treatments and complications in patients with type 2 diabetes: the RIACE Italian multicentre study. Journal of Internal Medicinen/a-n/a

  33. 33

    Jing-Bo Wang, Yan-Jun Zhang, Yan Zhang, Juan Guan, Li-Ying Chen, Chun-Hua Fu, Hong-Jun Du, Yu Sheng, Li Zhou, Yan-Fang Si, Yan Zhang. (2013) Negative correlation between serum syndecan-1 and apolipoprotein A1 in patients with type 2 diabetes mellitus. Acta Diabetologica 50:2, 111-115

  34. 34

    Ronald C.W. Ma, Juliana C.N. Chan. (2013) Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States. Annals of the New York Academy of Sciences 1281:1, 64-91

  35. 35

    Damian K Francis, Peter A Lazzarini, Trevor S Ferguson, Scott D Jen, Chisa Cumberbatch, Vivian Welch, Damian K Francis. Education of health professionals for preventing diabetic foot ulceration. In: Cochrane Database of Systematic Reviews. John Wiley & Sons, Ltd, 2013.

  36. 36

    , , R. C. W. Ma, C. Hu, C. H. Tam, R. Zhang, P. Kwan, T. F. Leung, G. N. Thomas, M. J. Go, K. Hara, X. Sim, J. S. K. Ho, C. Wang, H. Li, L. Lu, Y. Wang, J. W. Li, Y. Wang, V. K. L. Lam, J. Wang, W. Yu, Y. J. Kim, D. P. Ng, H. Fujita, K. Panoutsopoulou, A. G. Day-Williams, H. M. Lee, A. C. W. Ng, Y-J. Fang, A. P. S. Kong, F. Jiang, X. Ma, X. Hou, S. Tang, J. Lu, T. Yamauchi, S. K. W. Tsui, J. Woo, P. C. Leung, X. Zhang, N. L. S. Tang, H. Y. Sy, J. Liu, T. Y. Wong, J. Y. Lee, S. Maeda, G. Xu, S. S. Cherny, T. F. Chan, M. C. Y. Ng, K. Xiang, A. P. Morris, S. Keildson, R. Hu, L. Ji, X. Lin, Y. S. Cho, T. Kadowaki, E. S. Tai, E. Zeggini, M. I. McCarthy, K. L. Hon, L. Baum, B. Tomlinson, W. Y. So, Y. Bao, J. C. N. Chan, W. Jia. (2013) Genome-wide association study in a Chinese population identifies a susceptibility locus for type 2 diabetes at 7q32 near PAX4. Diabetologia

  37. 37

    X. Yang, Y. Wang, A. O. Y. Luk, W. Y. So, R. C. W. Ma, A. P. S. Kong, G. Xu, J. C. N. Chan. (2013) Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes. Endocrine Related Cancer 20:2, 161-171

  38. 38

    Diabetes Mellitus: A Pandemic in the Making. In: Understanding Diabetes. John Wiley & Sons, Inc., 2013:1-21.

  39. 39

    Muhammad Sajid Hamid Akash, Kanwal Rehman, Shuqing Chen. (2013) Role of inflammatory mechanisms in pathogenesis of type 2 diabetes mellitus. Journal of Cellular Biochemistry 114:3, 525-531

  40. 40

    Christine Y Lu, Dennis Ross-Degnan, Peter Stephens, Bao Liu, Anita K. Wagner. (2013) Changes in use of antidiabetic medications following price regulations in China (1999-2009). Journal of Pharmaceutical Health Services Research 4:1, 3-11

  41. 41

    Yu Cheng, Guo Wang, Wei Zhang, Lan Fan, Yao Chen, Hong-Hao Zhou. (2013) Effect of CYP2C9 and SLCO1B1 polymorphisms on the pharmacokinetics and pharmacodynamics of nateglinide in healthy Chinese male volunteers. European Journal of Clinical Pharmacology 69:3, 407-413

  42. 42

    Xiao-hui Guo, Xiao-feng Lv, Ping Han, Xiu-zhen Zhang, Hua-zhang Yang, Wen-ruo Duan, Yan Gao. (2013) Efficacy and safety of glimepiride as initial treatment in Chinese patients with Type 2 diabetes mellitus. Current Medical Research and Opinion 29:3, 169-174

  43. 43

    A. Otteman, A. Ishani. (2013) Comparing US and Chinese dialysis patients: an editorial on Cheng et al. Mortality rates among prevalent hemodialysis patients in Beijing: a comparison with USRDS data. Nephrology Dialysis Transplantation 28:3, 495-497

  44. 44

    Zachary T. Bloomgarden, Andrew Drexler, Daniel Einhorn, George Grunberger, Youfei Guan, Yehuda Handelsman, Jason Changjie Hu, Xiaoying Li, Jianming Liu, Weiqing Wang, Jianping Weng, Guang Ning. (2013) The Journal of Diabetes: Continuing the Dialogue. Journal of Diabetesn/a-n/a

  45. 45

    M. Kataoka, B. J. Venn, S. M. Williams, L. A. Te Morenga, I. M. Heemels, J. I. Mann. (2013) Glycaemic responses to glucose and rice in people of Chinese and European ethnicity. Diabetic Medicine 30:3, e101-e107

  46. 46

    Wenying Yang. (2013) Changing characteristics of the type 2 diabetes epidemic of China and other Asian countries. Journal of Diabetes Investigationn/a-n/a

  47. 47

    , Jin-Kui Yang, Lei Wang. (2013) Nateglinide in Combination with Metformin in Chinese Patients with Type 2 Diabetes Mellitus: A Post-Marketing Surveillance Study. Clinical Drug Investigation 33:3, 185-191

  48. 48

    Jing Shen, Yu Cheng, Qingwang Han, Yiming Mu, Weidong Han. (2013) Generating insulin-producing cells for diabetic therapy: Existing strategies and new development. Ageing Research Reviews 12:2, 469-478

  49. 49

    Chern-En Chiang, Shu Zhang, Hung Fat Tse, Wee Siong Teo, Razali Omar, Charn Sriratanasathavorn. (2013) Atrial fibrillation management in Asia: From the Asian expert forum on atrial fibrillation. International Journal of Cardiology 164:1, 21-32

  50. 50

    Hua Xu, Li-min Zhang, Jun Liu, Guan-xiong Ding, Qiang Ding, Hao-wen Jiang. (2013) The association between overall survival of prostate cancer patients and hypertension, hyperglycemia, and overweight in Southern China: a prospective cohort study. Journal of Cancer Research and Clinical Oncology

  51. 51

    Yong Tang, Xueyao Han, Xiuqin Sun, Chao Lv, Xiaomei Zhang, Wulan Guo, Qian Ren, Yingying Luo, Xiuying Zhang, Xianghai Zhou, Linong Ji. (2013) Association study of a common variant near IRS1 with type 2 diabetes mellitus in Chinese Han population. Endocrine 43:1, 84-91

  52. 52

    Lei Liu, Xu Yang, Haoran Wang, Guanglin Cui, Yujun Xu, Peihua Wang, Gang Yuan, Xiaojing Wang, Hu Ding, Dao Wen Wang. (2013) Association between variants of EXT2 and type 2 diabetes: a replication and meta-analysis. Human Genetics 132:2, 139-145

  53. 53

    Charles H. Hennekens, Felicita Andreotti. (2013) Leading Avoidable Cause of Premature Deaths Worldwide: Case for Obesity. The American Journal of Medicine 126:2, 97-98

  54. 54

    Xue-Hui Meng, Yi-Xiang Huang, Dong-Ping Rao, Qiu Zhang, Qing Liu. (2013) Comparison of three data mining models for predicting diabetes or prediabetes by risk factors. The Kaohsiung Journal of Medical Sciences 29:2, 93-99

  55. 55

    Zhao-Shun Jiang, Su-Xia Wang, Hong-Xia Jia, Jing Wang, Yuan-Tao Liu. (2013) Association of Toll-Like Receptor 4 Polymorphisms with Type 2 Diabetes Mellitus. Inflammation 36:1, 251-257

  56. 56

    Bin Wang, Raj Medapalli, Jin Xu, Weijing Cai, Xue Chen, John C. He, Jaime Uribarri. (2013) Effects of a whole rice diet on metabolic parameters and inflammatory markers in prediabetes. e-SPEN Journal 8:1, e15-e20

  57. 57

    Junlong Zhang, Xinhua Xiao, Linong Ji. (2013) Epigenetic disorder plays a fundamental role in the etiology of type 2 diabetes. Wuhan University Journal of Natural Sciences 18:1, 9-19

  58. 58

    Dan-Feng Xu, Jian-Qin Sun, Min Chen, Yan-Qiu Chen, Hua Xie, Wei-Jia Sun, Yi-Fan Lin, Jing-Jing Jiang, Wei Sun, Ai-Fang Chen, Qian-Ru Tang. (2013) Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial. British Journal of Nutrition 109:03, 487-492

  59. 59

    Ting-Ting Du, Ping Yin, Jian-Hua Zhang, Dan Zhang, Wei Shi, Xue-Feng Yu. (2013) Comparison of the performance of HbA1c and fasting plasma glucose in identifying dysglycaemic status in Chinese high-risk subjects. Clinical and Experimental Pharmacology and Physiology 40:2, 63-68

  60. 60

    Ilhan Satman, Beyhan Omer, Yildiz Tutuncu, Sibel Kalaca, Selda Gedik, Nevin Dinccag, Kubilay Karsidag, Sema Genc, Aysegul Telci, Bulent Canbaz, Fulya Turker, Temel Yilmaz, Bekir Cakir, Jaakko Tuomilehto. (2013) Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults. European Journal of Epidemiology 28:2, 169-180

  61. 61

    ChunXia Wang, FeiFan Guo. (2013) Branched chain amino acids and metabolic regulation. Chinese Science Bulletin

  62. 62

    Xu Zhao, Qing Ye, Kang Xu, Jinluo Cheng, Yanqin Gao, Qian Li, Juan Du, Hui Shi, Ling Zhou. (2013) Single-nucleotide polymorphisms inside microRNA target sites influence the susceptibility to type 2 diabetes. Journal of Human Genetics

  63. 63

    Judith Wylie-Rosett, Linda M. Delahanty. The Role of Diet in the Prevention and Treatment of Diabetes. In: Nutrition in the Prevention and Treatment of Disease. Elsevier, 2013:615-628.

  64. 64

    Jie Hu, Kenneth J Gruber, Huaping Liu, Hong Zhao, Alexandra A Garcia. (2013) Diabetes knowledge among older adults with diabetes in Beijing, China. Journal of Clinical Nursing 22:1-2, 51-60

  65. 65

    Yanbin Gao, Hui Zhou, Huiling Zhao, Xingzhong Feng, Jianhua Feng, Yi Li, Hong Zhang, Hao Lu, Qiuhai Qian, Xiuchen Yu, Ning Zhang, Jiangyi Yu, Qing Ni, Mingzheng Pan. (2013) Clinical Research of Traditional Chinese Medical Intervention on Impaired Glucose Tolerance. The American Journal of Chinese Medicine 41:01, 21-32

  66. 66

    X. Wu, Q. Chang, Y. Zhang, X. Zou, L. Chen, L. Zhang, L. Lv, B. Liang. (2013) Relationships between body weight, fasting blood glucose concentration, sex and age in tree shrews ( Tupaia belangeri chinensis ). Journal of Animal Physiology and Animal Nutritionn/a-n/a

  67. 67

    Juan Huang, Kaipeng Huang, Tian Lan, Xi Xie, Xiaoyan Shen, Peiqing Liu, Heqing Huang. (2013) Curcumin ameliorates diabetic nephropathy by inhibiting the activation of the SphK1-S1P signaling pathway. Molecular and Cellular Endocrinology 365:2, 231-240

  68. 68

    Yinzhong Shen, Zhenyan Wang, Li Liu, Renfang Zhang, Yufang Zheng, Hongzhou Lu. (2013) Prevalence of hyperglycemia among adults with newly diagnosed HIV/AIDS in China. BMC Infectious Diseases 13:1, 79

  69. 69

    Bu-Chun Zhang, Wei-Ming Li, Meng-Yun Zhu, Ya-Wei Xu. (2013) Association of TCF7L2 gene polymorphisms with type 2 diabetes mellitus in Han Chinese population: A meta-analysis. Gene 512:1, 76-81

  70. 70

    Sanjay Basu, David Stuckler, Martin McKee, Gauden Galea. (2013) Nutritional determinants of worldwide diabetes: an econometric study of food markets and diabetes prevalence in 173 countries. Public Health Nutrition 16:01, 179-186

  71. 71

    Penny Gordon-Larsen, Linda S. Adair, James B. Meigs, Elizabeth Mayer-Davis, Amy Herring, Sheng-kai Yan, Bing Zhang, Shufa Du, Barry M. Popkin. (2013) Discordant risk: Overweight and cardiometabolic risk in Chinese adults. Obesity 21:1, E166-E174

  72. 72

    Jie Wu, Ling Qiu, Wen-hua Yan, Xin-qi Cheng, Wei Wu, Xiu-zhi Guo, Hai-tao Ding, Hui-juan Han, Shao-mei Han, Guang-jin Zhu. (2013) Serum γ-glutamyltransferase and uric acid levels are associated with impaired fasting glucose in adults from Inner Mongolia, China. BMC Public Health 13:1, 294

  73. 73

    Yi Min Cui, Xiao Hui Guo, Dong Mei Zhang, Lai San Tham, Cheng Cai tang, Kenneth Mace, Helle Linnebjerg. (2013) Single and multiple dose pharmacokinetics, safety, and tolerability of exenatide once weekly in Chinese patients with type 2 diabetes mellitus. Journal of Diabetesn/a-n/a

  74. 74

    Gang chen, Yuan xu, Yinghua lin, Xiaolan lai, Jin yao, Baoying huang, Zichun chen, Huibin huang, Xianguo fu, Lixiang lin, Shenghan lai, Junping wen. (2013) Association study of genetic variants of 17 diabetes-related genes/loci and cardiovascular risk, diabetic nephropathy in the Chinese She population. Journal of Diabetesn/a-n/a

  75. 75

    Junling Gao, Jingli Wang, Yaocheng Zhu, Jinming Yu. (2013) Validation of an information--motivation--behavioral skills model of self-care among Chinese adults with type 2 diabetes. BMC Public Health 13:1, 100

  76. 76

    Yihui Liu, Luosheng Wan, Zuoqi Xiao, Jingjing Wang, Yonglong Wang, Jiachun Chen. (2013) Antidiabetic Activity of Polysaccharides from Tuberous Root of Liriope spicata var. prolifera in KKAy Mice. Evidence-Based Complementary and Alternative Medicine 2013, 1-11

  77. 77

    Anne T. Reutens. (2013) Epidemiology of Diabetic Kidney Disease. Medical Clinics of North America 97:1, 1-18

  78. 78

    Junling Gao, Jingli Wang, Pinpin Zheng, Regine Haardörfer, Michelle C Kegler, Yaocheng Zhu, Hua Fu. (2013) Effects of self-care, self-efficacy, social support on glycemic control in adults with type 2 diabetes. BMC Family Practice 14:1, 66

  79. 79

    Xi Li, Feng-Mei Lian, Dong Guo, Lan Fan, Jie Tang, Jing-Bo Peng, Hong-Wen Deng, Zhao-Qian Liu, Xin-Hua Xiao, Yan-Rong Wang, Ke-Yi Qu, Sheng Deng, Qi Zhong, Yi-Ling Sha, Yan Zhu, Yu-Jing Bai, Xin-Yan Chen, Qiang Zhou, Hong-Hao Zhou, Xiao-Lin Tong, Wei Zhang. (2013) The rs1142345 in TPMT Affects the Therapeutic Effect of Traditional Hypoglycemic Herbs in Prediabetes. Evidence-Based Complementary and Alternative Medicine 2013, 1-8

  80. 80

    Y. Wang, Y. L. Zhang, Y. P. Wang, C.H. Lei, Z.L. Sun. (2012) A study on the association of serum 1,5-anhydroglucitol levels and the hyperglycemic excursions as measured by Continuous Glucose Monitoring System among Type 2 Diabetes in a Chinese Population. Diabetes/Metabolism Research and Reviewsn/a-n/a

  81. 81

    Pei-Bo Li, Wan-Ling Lin, Yong-Gang Wang, Wei Peng, Xue-Ying Cai, Wei-Wei Su. (2012) Antidiabetic activities of oligosaccharides of Ophiopogonis japonicus in experimental type 2 diabetic rats. International Journal of Biological Macromolecules 51:5, 749-755

  82. 82

    S. M. Attard, A. H. Herring, E. J. Mayer-Davis, B. M. Popkin, J. B. Meigs, P. Gordon-Larsen. (2012) Multilevel examination of diabetes in modernising China: what elements of urbanisation are most associated with diabetes?. Diabetologia 55:12, 3182-3192

  83. 83

    Zhaoyan Gu, Yingzhen Du, Yu Liu, Lichao Ma, Lin Li, Yanping Gong, Hui Tian, Chunlin Li. (2012) Effect of aging on islet beta-cell function and its mechanisms in Wistar rats. AGE 34:6, 1393-1403

  84. 84

    Jian Zhang, Fei Yan, Shenglan Tang. (2012) The Incoherence of China’s National Health Development Strategies. American Journal of Public Health 102:12, e14-e16

  85. 85

    Huixia Shen, Helen Edwards, Mary Courtney, Jan McDowell, Ming Wu. (2012) Peer-led diabetes self-management programme for community-dwelling older people in China: study protocol for a quasi-experimental design. Journal of Advanced Nursing 68:12, 2766-2777

  86. 86

    Tianjie Li, Xilin Zhu, Xiaopan Wu, Jingyun Li, Liping Pan, Pengtao Li, Zhenhui Xin, Harvest F. Gu, Ying Liu. (2012) Evaluation of the Association Between the ADRA2A Genetic Polymorphisms and Type 2 Diabetes in a Chinese Han Population. Genetic Testing and Molecular Biomarkers 16:12, 1424-1427

  87. 87

    Jiyuan Ding, Yanhong Zou, Ningpu Liu, Li Jiang, Xuetao Ren, Wei Jia, Torkel Snellingen, Virasakdi Chongsuvivatwong, Xipu Liu. (2012) Strategies of Digital Fundus Photography for Screening Diabetic Retinopathy in a Diabetic Population in Urban China. Ophthalmic Epidemiology 19:6, 414-419

  88. 88

    Ji-Yan Cong, Yue Zhao, Qun-Yan Xu, Chun-De Zhong, Qiu-Ling Xing. (2012) Health-related quality of life among Tianjin Chinese patients with type 2 diabetes: A cross-sectional survey. Nursing & Health Sciences 14:4, 528-534

  89. 89

    Xueyao Han, Jianzhong Xiao, Qian Ren, Yong Tang, Wenying Yang, Linong Ji. (2012) Evaluation of variant A45T in NEUROD1/BETA2 for its association with type 2 diabetes mellitus. Endocrine

  90. 90

    Quan Yi, Xiao-En He, Kai-Fey Luo, Gen-Shui Zhang, Ying-Hua Liu, Qin Xue, Ning Hou, Wen-Liang Chen, Jian-Dong Luo. (2012) Protection of Long-Term Treatment With Huang-Lian-Jie-Du-Tang on Vascular Endothelium in Rats With Type 2 Diabetes Mellitus. Current Therapeutic Research 73:6, 174-185

  91. 91

    Yan Bi, Dalong Zhu, Yali Jing, Yun Hu, Wenhuan Feng, Shanmei Shen, Guoyu Tong, Xujun Shen, Tingting Yu, Dan Song, Donghui Yang. (2012) Decreased beta cell function and insulin sensitivity contributed to increasing fasting glucose in Chinese. Acta Diabetologica 49:S1, 51-58

  92. 92

    Francis CC Chow, Siew-Pheng Chan, Chii-Min Hwu, Sompongse Suwanwalaikorn, Akira YT Wu, Susan Yu Gan, Manuel B Zacarias. (2012) Challenges in achieving optimal glycemic control in type 2 diabetes patients with declining renal function: The Southeast Asia perspective. Journal of Diabetes Investigation 3:6, 481-489

  93. 93

    Yufang Bi, Tiange Wang, Min Xu, Yu Xu, Mian Li, Jieli Lu, Xiaolin Zhu, Guang Ning. (2012) Advanced research on risk factors of type 2 diabetes. Diabetes/Metabolism Research and Reviews 28, 32-39

  94. 94

    Jinlei Nie, Zhaowei Kong, Julien S. Baker, Tom K. Tong, Seng Hong Lei, Qingde Shi. (2012) Acute changes in glycemic homeostasis in response to brief high-intensity intermittent exercise in obese adults. Journal of Exercise Science & Fitness 10:2, 97-100

  95. 95

    C. Mary Schooling, Elizabeth A. Kelvin, Heidi E. Jones. (2012) Alanine transaminase has opposite associations with death from diabetes and ischemic heart disease in NHANES III. Annals of Epidemiology 22:11, 789-798

  96. 96

    Ping Gu, Weimin Jiang, Maowei Cheng, Bin Lu, Jiaqing Shao, Hong Du, Shisen Jiang. (2012) Glucose Metabolism in Outpatients with New-Onset Hypertension in Chinese Han Population. Clinical and Experimental Hypertension 34:7, 474-481

  97. 97

    Chun Wang, Hong Li, Sheng-Guang Chen, Jin-Wei He, Chun-Jun Sheng, Xiao-Yun Cheng, Shen Qu, Ke-Sheng Wang, Mei-Ling Lu, Yong-Chun Yu. (2012) The skeletal effects of thiazolidinedione and metformin on insulin-resistant mice. Journal of Bone and Mineral Metabolism 30:6, 630-637

  98. 98

    Justin B. Echouffo-Tcheugui, Mary Mayige, Anthonia Okeoghene Ogbera, Eugene Sobngwi, Andre P. Kengne. (2012) Screening for hyperglycemia in the developing world: Rationale, challenges and opportunities. Diabetes Research and Clinical Practice 98:2, 199-208

  99. 99

    Linong Ji. (2012) From Kingdom to Kingdom, but hopefully not again. Diabetes Research and Clinical Practice 98:2, 173-174

  100. 100

    Hang Li, Brian Oldenburg, Catherine Chamberlain, Adrienne O’Neil, Bin Xue, Damien Jolley, Robert Hall, Zhong Dong, Yan Guo. (2012) Diabetes prevalence and determinants in adults in China mainland from 2000 to 2010: A systematic review. Diabetes Research and Clinical Practice 98:2, 226-235

  101. 101

    Huayin Cai, Junfeng Cai, Geng Tao. (2012) Association of toll-like receptor 4 polymorphisms with type 2 diabetes mellitus. APMISn/a-n/a

  102. 102

    Xiaopei Cao, Zilian Wang, Chijiao Yang, Xiaoqing Mo, Lingling Xiu, Yangbing Li, Haipeng Xiao. (2012) Comprehensive Intensive Therapy for Chinese Gestational Diabetes Benefits Both Newborns and Mothers. Diabetes Technology & Therapeutics 14:11, 1002-1007

  103. 103

    Michael M Engelgau, Edward W Gregg. (2012) Tackling the global diabetes burden: will screening help?. The Lancet 380:9855, 1716-1718

  104. 104

    Federico Soriguer, Natalia Colomo, Gabriel Olveira, Eduardo García-Fuentes, Isabel Esteva, María Soledad Ruiz de Adana, Sonsoles Morcillo, Nuria Porras, Sergio Valdés, Gemma Rojo-Martínez. (2012) White rice consumption and risk of type 2 diabetes. Clinical Nutrition

  105. 105

    Sauwanan Bumrerraj, Janusz Kaczorowski, Pattapong Kessomboon, Bandit Thinkhamrop, Chatchalit Rattarasarn. (2012) Diagnostic performance of 2h postprandial capillary and venous glucose as a screening test for abnormal glucose tolerance. Primary Care Diabetes 6:3, 207-211

  106. 106

    Justin B. Echouffo-Tcheugui, Anastase Dzudie, Marielle E. Epacka, Simeon P. Choukem, Marie S. Doualla, Henry Luma, Andre P. Kengne. (2012) Prevalence and determinants of undiagnosed diabetes in an urban sub-Saharan African population. Primary Care Diabetes 6:3, 229-234

  107. 107

    Liyong Zhu, Zhaohui Mo, Xiangwu Yang, Shengping Liu, Guohui Wang, Pengzhou Li, Juan Tan, Fei Ye, Jeff Strain, Ibrahim Im, Shaihong Zhu. (2012) Effect of Laparoscopic Roux-en-Y Gastroenterostomy with BMI < 35 kg/m2 in Type 2 Diabetes Mellitus. Obesity Surgery 22:10, 1562-1567

  108. 108

    Yan Lin, Liang Li, Fengling Mi, Juan Du, Yaqiong Dong, Zhaoliang Li, Wenbo Qi, Xiangling Zhao, Ying Cui, Fengying Hou, Rony Zachariah, Anil Kapur, Knut Lönnroth, Anthony D. Harries. (2012) Screening patients with Diabetes Mellitus for Tuberculosis in China. Tropical Medicine & International Health 17:10, 1302-1308

  109. 109

    Liang Li, Yan Lin, Fengling Mi, Shouyong Tan, Bing Liang, Chaojun Guo, Lian Shi, Li Liu, Fang Gong, Yuanyuan Li, Jingyu Chi, Rony Zachariah, Anil Kapur, Knut Lönnroth, Anthony D. Harries. (2012) Screening of patients with tuberculosis for diabetes mellitus in China. Tropical Medicine & International Health 17:10, 1294-1301

  110. 110

    Zhijie Yu, Liang Sun, Qibin Qi, Hongyu Wu, Ling Lu, Chen Liu, Huaixing Li, Xu Lin. (2012) Hypertriglyceridemic waist, cytokines and hyperglycaemia in Chinese. European Journal of Clinical Investigation 42:10, 1100-1111

  111. 111

    P. Katchunga, B. Masumbuko, M. Belma, Z. Kashongwe Munogolo, M.-P. Hermans, J.-R. M’Buyamba-Kabangu. (2012) Age and living in an urban environment are major determinants of diabetes among South Kivu Congolese adults. Diabetes & Metabolism 38:4, 324-331

  112. 112

    Yiping Li, Ying Yang, Li Shi, Xianli Li, Ying Zhang, Yufeng Yao. (2012) The association studies of ADIPOQ with type 2 diabetes mellitus in Chinese populations. Diabetes/Metabolism Research and Reviews 28:7, 551-559

  113. 113

    Hai-Yun Wu, Zhong-Hua Sun, Dong-Ping Cao, Liu-Xin Wu, Qiang Zeng. (2012) Cardiovascular health status in Chinese adults in urban areas: Analysis of the Chinese Health Examination Database 2010. International Journal of Cardiology

  114. 114

    Tingting Liu. (2012) A Concept Analysis of Self-Efficacy Among Chinese Elderly with Diabetes Mellitus. Nursing Forum 47:4, 226-235

  115. 115

    Y. Sato, Y. Yano, S. Fujimoto, T. Konta, K. Iseki, T. Moriyama, K. Yamagata, K. Tsuruya, H. Yoshida, K. Asahi, I. Kurahashi, Y. Ohashi, T. Watanabe. (2012) Glycohemoglobin not as predictive as fasting glucose as a measure of prediabetes in predicting proteinuria. Nephrology Dialysis Transplantation 27:10, 3862-3868

  116. 116

    Chong Tian, Rui Zhang, Xiaolei Ye, Changhui Zhang, Xin Jin, Yukio Yamori, Liping Hao, Xiufa Sun, Chenjiang Ying. (2012) Resveratrol ameliorates high-glucose-induced hyperpermeability mediated by caveolae via VEGF/KDR pathway. Genes & Nutrition

  117. 117

    Yuzheng Xue, Yingyue Sheng, Hong Dai, Haiyan Cao, Zongliang Liu, Zhaoshen Li. (2012) Risk of development of acute pancreatitis with pre-existing diabetes. European Journal of Gastroenterology & Hepatology 24:9, 1092-1098

  118. 118

    Gui-Ke Zou, Ying-Liang Song, Wei Zhou, Miao Yu, Li-Hua Liang, Dao-Cai Sun, De-Hua Li, Zai-Xi Deng, Wen-Zhong Zhu. (2012) Effects of local delivery of bFGF from PLGA microspheres on osseointegration around implants in diabetic rats. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 114:3, 284-289

  119. 119

    Xianhao Jia, Qin Liang, Fanglu Chi, Wenjun Cao. (2012) Otomycosis in Shanghai: aetiology, clinical features and therapy. Mycoses 55:5, 404-409

  120. 120

    Weihui YU, Cheng HU, Weiping JIA. (2012) Genetic advances of type 2 diabetes in Chinese populations. Journal of Diabetes 4:3, 213-220

  121. 121

    Zachary T. BLOOMGARDEN. (2012) Diabetes: East meets West. The Joint American Association of Clinical Endocrinologists-Chinese Society of Endocrinology (AACE-CSE) Symposium. Journal of Diabetes 4:3, 221-226

  122. 122

    Yu Liao, Yufei Xiang, Zhiguang Zhou. (2012) Diagnostic criteria of latent autoimmune diabetes in adults (LADA): a review and reflection. Frontiers of Medicine 6:3, 243-247

  123. 123

    Sulin Cheng, Urho M. Kujala. (2012) Exercise in type 2 diabetes: The mechanisms of resistance and endurance training. Journal of Sport and Health Science 1:2, 65-66

  124. 124

    NUOVO Jim, Xiao-wei YANG, Chao-xing LI, Huan ZENG. (2012) Changes in management mode for type 2 diabetes. Academic Journal of Second Military Medical University 32:3, 324-327

  125. 125

    Mary Beth Weber, Reena Oza-Frank, Lisa R. Staimez, Mohammed K. Ali, K.M. Venkat Narayan. (2012) Type 2 Diabetes in Asians: Prevalence, Risk Factors, and Effectiveness of Behavioral Intervention at Individual and Population Levels. Annual Review of Nutrition 32:1, 417-439

  126. 126

    Zhiyong Yin, Linni Fan, Hongbing Jia, Congye Li, Rongqing Zhang, Haichang Wang. (2012) S1P1 and S1P3 are potential markers of cardiac microangiopathy in diabetes. Medical Hypotheses 79:2, 168-170

  127. 127

    C. Pan, X. Xing, P. Han, S. Zheng, J. Ma, J. Liu, X. Lv, J. Lu, G. Bader, . (2012) Efficacy and tolerability of vildagliptin as add-on therapy to metformin in Chinese patients with type 2 diabetes mellitus. Diabetes, Obesity and Metabolism 14:8, 737-744

  128. 128

    Xiaolong Zhao, HuangFu Chang Mei, Lili Chen, Lin Jiang, Min He, Jian Chen, Zhupeng Hu, Hongying Ye, Hong Hu, Linuo Zhou, Yiming Li, Renming Hu. (2012) An increased level of haemoglobin A1C predicts a poorer clinical outcome in patients with acute pancreatitis. Clinical Endocrinology 77:2, 241-245

  129. 129

    Kirtikar Shukla, Piyush Dikshit, Rimi Shukla, Jasvinder K. Gambhir. (2012) The Aqueous Extract of Withania coagulans Fruit Partially Reverses Nicotinamide/Streptozotocin-Induced Diabetes Mellitus in Rats. Journal of Medicinal Food 15:8, 718-725

  130. 130

    Karen N Eggleston, Victor R Fuchs. (2012) The New Demographic Transition: Most Gains in Life Expectancy Now Realized Late in Life. Journal of Economic Perspectives 26:3, 137-156

  131. 131

    Fan Zhang, Yuan Yang, Dayi Hu, Han Lei, Yang Wang. (2012) Percutaneous coronary intervention (PCI) versus coronary artery bypass grafting (CABG) in the treatment of diabetic patients with multi-vessel coronary disease: A meta-analysis. Diabetes Research and Clinical Practice 97:2, 178-184

  132. 132

    Yali Cao, Wenge Li, Guannan Yang, Yutian Liu, Xin Li. (2012) Diabetes and hypertension have become leading causes of CKD in Chinese elderly patients: a comparison between 1990–1991 and 2009–2010. International Urology and Nephrology 44:4, 1269-1276

  133. 133

    Ming Zhang, Li Chen. (2012) Berberine in type 2 diabetes therapy: a new perspective for an old antidiarrheal drug?. Acta Pharmaceutica Sinica B 2:4, 379-386

  134. 134

    Bin Wang, Daying Wei, Chunxiu Wang, Jianhua Zhang, Li Pan, Mingju Ma, Fang Xue, Zhenglai Wu, Guangliang Shan. (2012) Prevalence of dyslipidemia and associated factors in the Yi farmers and migrants of southwestern China. Atherosclerosis 223:2, 512-518

  135. 135

    Yu Liu, Suozhu Shi, Zhaoyan Gu, Yingzhen Du, Minyan Liu, Shuangtong Yan, Jianjun Gao, Jian Li, Yinghong Shao, Wenwen Zhong, Xiangmei Chen, Chunlin Li. (2012) Impaired autophagic function in rat islets with aging. AGE

  136. 136

    De-Kun Li, Jeannette R. Ferber, Roxana Odouli, Charles P. Quesenberry. (2012) A Prospective Study of In-utero Exposure to Magnetic Fields and the Risk of Childhood Obesity. Scientific Reports 2,

  137. 137

    Lindsay M. Jaacks, Judith Wylie-Rosett, Elizabeth J. Mayer-Davis. Diabetes. In: Present Knowledge in Nutrition. Wiley-Blackwell, 2012:806-832.

  138. 138

    LU Ju-ming, GUO Xiao-hui, LV Xiao-feng, LI Yan-bing, YAN Li, XUE Yao-ming. (2012) Effects of Nateglinide on Postprandial Plasma Glucose Excursion and Metabolism of Lipids in Chinese Patients with Type 2 DiabetesA 4-week, randomized, active-control, open-label, parallel-group, multicenter trial. Current Medical Research and Opinion1-24

  139. 139

    Xilin Yang, Wing-Yee So, Ronald CW Ma, Alice PS Kong, Gang Xu, Juliana CN Chan. (2012) Diabetes and cancer: the mechanistic implications of epidemiological analyses from the Hong Kong Diabetes Registry. Diabetes/Metabolism Research and Reviews 28:5, 379-387

  140. 140

    Zumin Shi, Ping Zhou, Chun Zhang. (2012) Prevalence of chronic kidney disease in China. The Lancet 380:9838, 214

  141. 141

    S. Yan, J. Li, S. Li, B. Zhang, S. Du, P. Gordon-Larsen, L. Adair, B. Popkin. (2012) The expanding burden of cardiometabolic risk in China: the China Health and Nutrition Survey. Obesity Reviewsno-no

  142. 142

    Penny Gordon-Larsen, Linda S. Adair, James B. Meigs, Elizabeth Mayer-Davis, Amy Herring, Sheng-kai Yan, Bing Zhang, Shufa Du, Barry M. Popkin. (2012) Discordant Risk: Overweight and Cardiometabolic Risk in Chinese Adults. Obesity

  143. 143

    Li-Juan Li, Jing-Xia Zhou, Hong-Tao Chen, Yan-Ling Song, Yao-Ming Xue. (2012) Effect of HbA1c combined FPG on screening diabetes in health check-up. Asian Pacific Journal of Tropical Medicine 5:6, 472-475

  144. 144

    Lal B. Rawal, Robyn J. Tapp, Emily D. Williams, Carina Chan, Shajahan Yasin, Brian Oldenburg. (2012) Prevention of Type 2 Diabetes and Its Complications in Developing Countries: A Review. International Journal of Behavioral Medicine 19:2, 121-133

  145. 145

    Ting Lu, Hongguang Sheng, Johnna Wu, Yuan Cheng, Jianming Zhu, Yan Chen. (2012) Cinnamon extract improves fasting blood glucose and glycosylated hemoglobin level in Chinese patients with type 2 diabetes. Nutrition Research

  146. 146

    Miaoying Zhang, Fengxia Guo, Yuezhen Tu, Wieland Kiess, Chengjun Sun, Xi Li, Wei Lu, Feihong LUO. (2012) Further increase of obesity prevalence in Chinese children and adolescents - cross-sectional data of two consecutive samples from the city of Shanghai from 2003 to 2008. Pediatric Diabetes 9999:9999, n/a-n/a

  147. 147

    Weili Xu, Zhongliang Xu, Junting Jia, Yun Xie, Hui-Xin Wang, Xiuying Qi. (2012) Detection of Prediabetes and Undiagnosed Type 2 Diabetes: A Large Population-Based Study. Canadian Journal of Diabetes 36:3, 108-113

  148. 148

    Rajendra Pradeepa, Dorairaj Prabhakaran, Viswanathan Mohan. (2012) Emerging Economies and Diabetes and Cardiovascular Disease. Diabetes Technology & Therapeutics 14:S1, S-59-S-67

  149. 149

    Xing-Bo Cheng, Yi-Ting Hsieh, Shih-Te Tu, Ming-Chia Hsieh. (2012) Obesity and low target attainment rates in Chinese with type 2 diabetes. European Journal of Internal Medicine 23:4, e101-e105

  150. 150

    C. M. Schooling, L. L. Hui, L. M. Ho, T.-H. Lam, G. M. Leung. (2012) Cohort Profile: 'Children of 1997': a Hong Kong Chinese birth cohort. International Journal of Epidemiology 41:3, 611-620

  151. 151

    Weihua Liu, Tian Lan, Xi Xie, Kaipeng Huang, Jing Peng, Juan Huang, Xiaoyan Shen, Peiqing Liu, Heqing Huang. (2012) S1P2 receptor mediates sphingosine-1-phosphate-induced fibronectin expression via MAPK signaling pathway in mesangial cells under high glucose condition. Experimental Cell Research 318:8, 936-943

  152. 152

    Douglas W. Zochodne. (2012) Reversing neuropathic deficits. Journal of the Peripheral Nervous System 17, 4-9

  153. 153

    Feng Lu, Yun Qian, Huizhang Li, Meihua Dong, Yudi Lin, Jiangbo Du, Yuan Lin, Jian Chen, Chong Shen, Guangfu Jin, Juncheng Dai, Zhibin Hu, Hongbing Shen. (2012) Genetic variants on chromosome 6p21.1 and 6p22.3 are associated with type 2 diabetes risk: a case–control study in Han Chinese. Journal of Human Genetics 57:5, 320-325

  154. 154

    Wayne H.-H. Sheu, Li-Nong Ji, Wannee Nitiyanant, Sei Hyun Baik, Donald Yin, Panagiotis Mavros, Siew-Pheng Chan. (2012) Hypoglycemia is associated with increased worry and lower quality of life among patients with type 2 diabetes treated with oral antihyperglycemic agents in the Asia-Pacific region. Diabetes Research and Clinical Practice 96:2, 141-148

  155. 155

    L. Korngut, C.H.E. Ma, J.A. Martinez, C.C. Toth, G.F. Guo, V. Singh, C.J. Woolf, D.W. Zochodne. (2012) Overexpression of human HSP27 protects sensory neurons from diabetes. Neurobiology of Disease

  156. 156

    Yinghua Lin, Yuan Xu, Gang Chen, Xiaolan Lai, Baoying Huang, Zichun Chen, Longteng Yao, Shaoheng Zhu, Jin Yao, Junping Wen, Huibin Huang, Caijing Lin. (2012) Diabetes and Its Chronic Complications in the She Ethnic Minority Group of China. Diabetes Technology <html_ent glyph="@amp;" ascii="&"/> Therapeutics 14:5, 430-439

  157. 157

    Justin B. Echouffo-Tcheugui, Samuel Dagogo-Jack. (2012) Preventing diabetes mellitus in developing countries. Nature Reviews Endocrinology 8:9, 557-562

  158. 158

    Frank W. Booth, Christian K. Roberts, Matthew J. Laye. Lack of Exercise Is a Major Cause of Chronic Diseases. In: Comprehensive Physiology. John Wiley & Sons, Inc., 2012.

  159. 159

    Brittany A. Rasmussen, Danna M. Breen, Ping Luo, Grace W.C. Cheung, Clair S. Yang, Biying Sun, Andrea Kokorovic, Weifang Rong, Tony K.T. Lam. (2012) Duodenal Activation of cAMP-Dependent Protein Kinase Induces Vagal Afferent Firing and Lowers Glucose Production in Rats. Gastroenterology 142:4, 834-843.e3

  160. 160

    Jitendra Kumar, Gaurav Sahai. (2012) Non-diabetic renal diseases in diabetics. Clinical Queries: Nephrology 1:2, 172-177

  161. 161

    Zhongqun Wang, Yicheng Jiang, Naifeng Liu, Liqun Ren, Yinghong Zhu, Yanli An, Dengyu Chen. (2012) Advanced glycation end-product Nɛ-carboxymethyl-Lysine accelerates progression of atherosclerotic calcification in diabetes. Atherosclerosis 221:2, 387-396

  162. 162

    Wenying Yang, Xiaofeng Lv, Qifu Li, Weiping Jia, Haoming Tian. (2012) A prospective study to optimize insulin treatment by switching to insulin glargine in type 2 diabetic patients previously uncontrolled on premixed insulin: the optimization study. Current Medical Research and Opinion1-9

  163. 163

    Wang Yong, Wei Shibo, Liu Jingang. (2012) Remission of Insulin Resistance in Type 2 Diabetic Patients After Gastric Bypass Surgery or Exenatide Therapy. Obesity Surgery

  164. 164

    X Chen, Y Zhao, Z Zhou, X Zhang, Q Li, L Bai, M Zhang. (2012) Prevalence and risk factors of diabetic retinopathy in Chongqing pre-diabetes patients. Eye

  165. 165

    Zheng Sun, Jingnan Chen, Jinyu Ma, Yue Jiang, Mingfu Wang, Guixing Ren, Feng Chen. (2012) Cynarin-Rich Sunflower (Helianthus annuus) Sprouts Possess Both Antiglycative and Antioxidant Activities. Journal of Agricultural and Food Chemistry120319070545001

  166. 166

    Shi Lin Lin, So Lun Lee, Lai Ling Hui, Shiu Lun Au Yeung, Michael A. Tse, Gabriel M. Leung, C. Mary. Schooling. (2012) Pubertal muscle mass and diabetes markers in chinese adolescents. American Journal of Human Biology 24:2, 183-185

  167. 167

    Liang Xu, Jost B. Jonas, Tong Tong Cui, Qi Sheng You, Ya Xing Wang, Hua Yang, Jian Jun Li, Wen Bin Wei, Qing Feng Liang, Shuang Wang, Xiao Hui Yang, Li Zhang. (2012) Beijing Eye Public Health Care Project. Ophthalmology

  168. 168

    Marie-Germaine Bousser. (2012) Stroke prevention: an update. Frontiers of Medicine 6:1, 22-34

  169. 169

    Douglas W. Zochodne. (2012) The challenges and beauty of peripheral nerve regrowth. Journal of the Peripheral Nervous System 17:1, 1-18

  170. 170

    Luxia Zhang, Fang Wang, Li Wang, Wenke Wang, Bicheng Liu, Jian Liu, Menghua Chen, Qiang He, Yunhua Liao, Xueqing Yu, Nan Chen, Jian-e Zhang, Zhao Hu, Fuyou Liu, Daqing Hong, Lijie Ma, Hong Liu, Xiaoling Zhou, Jianghua Chen, Ling Pan, Wei Chen, Weiming Wang, Xiaomei Li, Haiyan Wang. (2012) Prevalence of chronic kidney disease in China: a cross-sectional survey. The Lancet 379:9818, 815-822

  171. 171

    Sean M. Switzer, Emily G. Moser, Briana E. Rockler, Satish K. Garg. (2012) Intensive Insulin Therapy in Patients with Type 1 Diabetes Mellitus. Endocrinology and Metabolism Clinics of North America 41:1, 89-104

  172. 172

    Wen Huang, Hongbo Ren, Qiwen Ben, Quancai Cai, Wei Zhu, Zhaoshen Li. (2012) Risk of esophageal cancer in diabetes mellitus: a meta-analysis of observational studies. Cancer Causes & Control 23:2, 263-272

  173. 173

    Dong Zhao, Fan Zhao, Yan Li, Zheng Zheng. (2012) Projected and Observed Diabetes Epidemics in China and Beyond. Current Cardiology Reports 14:1, 106-111

  174. 174

    Y. Bi, L. Zeng, D. Zhu, J. Yan, Y. Zhang, G. Tong, P. Mu, S. Shen, Y. Hu, Q. Yu, H. Liang, J. Weng. (2012) Association of β-cell function and insulin sensitivity with fasting and 2-h plasma glucose in a large Chinese population. Diabetes, Obesity and Metabolism 14:2, 174-180

  175. 175

    Xin Wang, Ling Tao, Chun X. Hai. (2012) Redox-regulating role of insulin: The essence of insulin effect. Molecular and Cellular Endocrinology 349:2, 111-127

  176. 176

    Titus Augustine. (2012) SIMULTANEOUS PANCREAS AND KIDNEY TRANSPLANTATION IN DIABETES WITH RENAL FAILURE: THE GOLD STANDARD?. Journal of Renal Care 38, 115-124

  177. 177

    Ling Li, Yuqian Bao, Liangpu Peng, Huilin Gu, Chen Wang, Weiping Jia. (2012) Optimal Body Fat Percentage Cutoffs for Obesity in Chinese Adults. Clinical and Experimental Pharmacology and Physiologyn/a-n/a

  178. 178

    Yue Liu, Ke-ji Chen. (2012) Commentary atherosclerosis, vascular aging and therapeutic strategies. Chinese Journal of Integrative Medicine 18:2, 83-87

  179. 179

    (2012) Panretinal Photocoagulation for Diabetic Retinopathy. New England Journal of Medicine 366:3, 277-279
    Free Full Text

  180. 180

    Z.-J. Yang, J. Liu, J.-P. Ge, L. Chen, Z.-G. Zhao, W.-Y. Yang, . (2012) Prevalence of cardiovascular disease risk factor in the Chinese population: the 2007-2008 China National Diabetes and Metabolic Disorders Study. European Heart Journal 33:2, 213-220

  181. 181

    Jia Shen, Abhinav Goyal, Laurence Sperling. (2012) The Emerging Epidemic of Obesity, Diabetes, and the Metabolic Syndrome in China. Cardiology Research and Practice 2012, 1-5

  182. 182

    Jichun Yang, Yunfeng Zhou, Youfei Guan. (2012) PPARγ as a therapeutic target in diabetic nephropathy and other renal diseases. Current Opinion in Nephrology and Hypertension 21:1, 97-105

  183. 183

    Shaoqing Lei, Yanan Liu, Huimin Liu, Hong Yu, Hui Wang, Zhengyuan Xia. (2012) Effects of N-Acetylcysteine on Nicotinamide Dinucleotide Phosphate Oxidase Activation and Antioxidant Status in Heart, Lung, Liver and Kidney in Streptozotocin-Induced Diabetic Rats. Yonsei Medical Journal 53:2, 294

  184. 184

    Malgorzata Miszkurka, Slim Haddad, Etienne V Langlois, Ellen E Freeman, Seni Kouanda, Maria Victoria Zunzunegui. (2012) Heavy burden of non-communicable diseases at early age and gender disparities in an adult population of Burkina Faso: World Health Survey. BMC Public Health 12:1, 24

  185. 185

    Shan-hu Qiu, Zi-lin Sun, Xue Cai, Lili Liu, Bingquan Yang. (2012) Improving Patients' Adherence to Physical Activity in Diabetes Mellitus: A Review. Diabetes & Metabolism Journal 36:1, 1

  186. 186

    Liu He, Xun Tang, Yan Song, Na Li, Jingrong Li, Zongxin Zhang, Jianjiang Liu, Liping Yu, Haitao Xu, Jianguo Zhang, Yonghua Hu. (2012) Prevalence of cardiovascular disease and risk factors in a rural district of Beijing, China: a population-based survey of 58,308 residents. BMC Public Health 12:1, 34

  187. 187

    Yan Feng, Yumei Yang, Xuesong Ma, Kaiting Chen, Nannan Wu, Dongmei Wang, Pengjie Li, Minnan Wang, Qiang Li, Jinchao Zhang. (2012) Prevalence of diabetes among Han, Manchu and Korean ethnicities in the Mudanjiang area of China: A cross-sectional survey. BMC Public Health 12:1, 23

  188. 188

    Jitendra Kumar, Gaurav Sahai. (2012) Non-diabetic renal diseases in diabetics. Clinical Queries: Nephrology 1:2, 172

  189. 189

    Justin B. Echouffo-Tcheugui, Samuel Dagogo-Jack. (2012) Preventing diabetes mellitus in developing countries. Nature Reviews Endocrinology

  190. 190

    Hui Zuo, Zumin Shi, Baojun Yuan, Yue Dai, Gang Hu, Gaolin Wu, Akhtar Hussain. (2012) Interaction between physical activity and sleep duration in relation to insulin resistance among non-diabetic Chinese adults. BMC Public Health 12:1, 247

  191. 191

    Dongqing Yuan, Donglan Yuan, Qinghuai Liu. (2012) Association of the Receptor for Advanced Glycation End Products Gene Polymorphisms with Diabetic Retinopathy in Type 2 Diabetes: A Meta-Analysis. Ophthalmologica 227:4, 223-232

  192. 192

    Zachary Bloomgarden, Guang Ning. (2012) Diabetes: the prototypical non-communicable disease. Journal of Diabetesno-no

  193. 193

    Hong Zhang, Xiangcheng Zhang, Changjun Hu, Weiping Lu. (2012) Exenatide Reduces Urinary Transforming Growth Factor-ß1 and Type IV Collagen Excretion in Patients with Type 2 Diabetes and Microalbuminuria. Kidney and Blood Pressure Research 35:6, 483-488

  194. 194

    Jianzhong Xiao, Wenying Yang. (2012) Weight Loss Is Still an Essential Intervention in Obesity and its Complications: A Review. Journal of Obesity 2012, 1-6

  195. 195

    Christian M. Girgis, Jenny E. Gunton, N. Wah Cheung. (2012) The Influence of Ethnicity on the Development of Type 2 Diabetes Mellitus in Women with Gestational Diabetes: A Prospective Study and Review of the Literature. ISRN Endocrinology 2012, 1-7

  196. 196

    Pian-Hong Zhang, Zhong-Wen Chen, Duo Lv, Yu-Yang Xu, Wei-Ling Gu, Xu-Hui Zhang, Yuan-Luo Le, Hong-hong Zhu, Yi-Min Zhu. (2012) Increased risk of cancer in patients with type 2 diabetes mellitus: A retrospective cohort study in China. BMC Public Health 12:1, 567

  197. 197

    Dan-Feng Xu, Jian-Qin Sun, Min Chen, Yan-Qiu Chen, Hua Xie, Wei-Jia Sun, Yi-Fan Lin, Jing-Jing Jiang, Wei Sun, Ai-Fang Chen, Qian-Ru Tang. (2012) Effects of lifestyle intervention and meal replacement on glycaemic and body-weight control in Chinese subjects with impaired glucose regulation: a 1-year randomised controlled trial. British Journal of Nutrition1

  198. 198

    Zhong Xin, Chang Liu, Wen-Yan Niu, Jian-Ping Feng, Lei Zhao, Ya-Hong Ma, Lin Hua, Jin-Kui Yang. (2012) Identifying obesity indicators which best correlate with type 2 diabetes in a Chinese population. BMC Public Health 12:1, 732

  199. 199

    Tianpeng Zheng, Yun Gao, Haoming Tian. (2012) Relationship between blood lipid profiles and pancreatic islet β cell function in Chinese men and women with normal glucose tolerance: a cross-sectional study. BMC Public Health 12:1, 634

  200. 200

    Mark A Hanson, Peter D Gluckman, Ronald CW Ma, Priya Matzen, Regien G Biesma. (2012) Early life opportunities for prevention of diabetes in low and middle income countries. BMC Public Health 12:1, 1025

  201. 201

    Qing-Lin Lou, Xiao-Jun Ouyang, Liu-Bao Gu, Yong-Zhen Mo, Ronald Ma, Jennifer Nan, Alice Kong, Wing-Yee So, Gary Ko, Juliana Chan, Chun-Chung Chow, Rong-Wen Bian. (2012) Chronic Kidney Disease and Associated Cardiovascular Risk Factors in Chinese with Type 2 Diabetes. Diabetes & Metabolism Journal 36:6, 433

  202. 202

    Shengsheng Liu, Anhua Bi, Dongbo Fu, Hua Fu, Wei Luo, Xiaoying Ma, Liyan Zhuang. (2012) Effectiveness of using group visit model to support diabetes patient self-management in rural communities of Shanghai: a randomized controlled trial. BMC Public Health 12:1, 1043

  203. 203

    Longyi Zeng, Hongyun Lu, Hongrong Deng, Panwei Mu, Xiaofeng Li, Manman Wang. (2012) Noninferiority Effects on Glycemic Control and β-Cell Function Improvement in Newly Diagnosed Type 2 Diabetes Patients: Basal Insulin Monotherapy Versus Continuous Subcutaneous Insulin Infusion Treatment. Diabetes Technology <html_ent glyph="@amp;" ascii="&"/> Therapeutics 14:1, 35-42

  204. 204

    Satish K. Garg. (2012) Rising Epidemic of Diabetes and Hypertension in Asia. Diabetes Technology <html_ent glyph="@amp;" ascii="&"/> Therapeutics 14:1, 1-2

  205. 205

    Yufei Xiang, Gan Huang, Weidong Zhou, Zhihong Che, Pengcheng Zhou, Zhiguang Zhou. (2012) Prevalence of metabolic syndrome (MetS) in Chinese subjects gradually increased with impaired glucose homeostasis: a multicenter, clinical based, cross-sectional study. BMC Public Health 12:1, 675

  206. 206

    Xiaolong Zhao, Xiaoming Zhu, Hengsheng Zhang, Weiwei Zhao, Jinhui Li, Yonghui Shu, Songwu Li, Minghui Yang, Linghu Cai, Jiping Zhou, Yiming Li. (2012) Prevalence of diabetes and predictions of its risks using anthropometric measures in southwest rural areas of China. BMC Public Health 12:1, 821

  207. 207

    Meilin Zhang, Yuxia Gao, Hong Chang, Xuan Wang, Dongmei Liu, Zongjian Zhu, Guowei Huang. (2012) Hypertriglyceridemic-waist phenotype predicts diabetes: a cohort study in Chinese urban adults. BMC Public Health 12:1, 1081

  208. 208

    Tsung O. Cheng. (2012) Cardiovascular health, risks and diseases in contemporary China. International Journal of Cardiology 154:2, 233-242

  209. 209

    S. Garg, T. Bailey, T. DeLuzio, D. Pollom. (2011) Preference for a new prefilled insulin pen compared with the original pen. Current Medical Research and Opinion 27:12, 2323-2333

  210. 210

    Weiqing Wang, Ruifang Bu, Qing Su, Jianying Liu, Guang Ning. (2011) Randomized study of repaglinide alone and in combination with metformin in Chinese subjects with type 2 diabetes naive to oral antidiabetes therapy. Expert Opinion on Pharmacotherapy 12:18, 2791-2799

  211. 211

    Zhi-Yin Yang, Zhen Yang, Lifang Zhu, Chengxuan Qiu. (2011) Human Behaviors Determine Health: Strategic Thoughts on the Prevention of Chronic Non-communicable Diseases in China. International Journal of Behavioral Medicine 18:4, 295-301

  212. 212

    Yong Zhao, Zhaoshun Jiang, Chengshan Guo. (2011) New hope for type 2 diabetics: Targeting insulin resistance through the immune modulation of stem cells. Autoimmunity Reviews 11:2, 137-142

  213. 213

    Qingqing Lou, Liaofang Wu, Xia Dai, Meijuan Cao, Yu Ruan. (2011) Diabetes education in mainland China—A systematic review of the literature. Patient Education and Counseling 85:3, 336-347

  214. 214

    S. K. H. Wong, A. P. S. Kong, W. Y. So, B. Y. S. Tsung, P. Y. P. Yau, J. C. N. Chan, E. K. W. Ng. (2011) Use of laparoscopic sleeve gastrectomy and adjustable gastric banding for suboptimally controlled diabetes in Hong Kong. Diabetes, Obesity and Metabolismno-no

  215. 215

    David R. Whiting, Leonor Guariguata, Clara Weil, Jonathan Shaw. (2011) IDF Diabetes Atlas: Global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Research and Clinical Practice 94:3, 311-321

  216. 216

    Lei Chen, Dianna J. Magliano, Paul Z. Zimmet. (2011) The worldwide epidemiology of type 2 diabetes mellitus—present and future perspectives. Nature Reviews Endocrinology

  217. 217

    Ping Zeng, Xuefeng Zhu, Yi Zhang, Shu Wang, Tiemei Zhang. (2011) Metabolic syndrome and the development of type 2 diabetes among professionals living in Beijing, China. Diabetes Research and Clinical Practice 94:2, 299-304

  218. 218

    Ralf Altmeyer. (2011) Global Biotech goes China - Institut Pasteur Shanghai launches a unique platform for global biotech companies in China. Biotechnology Journal 6:11, 1303-1304

  219. 219

    Tsung O. Cheng. (2011) Cardiovascular health, risks and diseases in contemporary China. International Journal of Cardiology 152:3, 285-294

  220. 220

    Mingqing Huang, Youliang Xie, Lidian Chen, Kedan Chu, Shuisheng Wu, Jinjian Lu, Xiuping Chen, Yitao Wang, Xiaoping Lai. (2011) Antidiabetic Effect of the Total Polyphenolic Acids Fraction from Salvia miltiorrhiza Bunge in Diabetic Rats. Phytotherapy Researchn/a-n/a

  221. 221

    Wenying Yang, Chang Yu Pan, Conrad Tou, June Zhao, Ingrid Gause-Nilsson. (2011) Efficacy and safety of saxagliptin added to metformin in Asian people with type 2 diabetes mellitus: A randomized controlled trial. Diabetes Research and Clinical Practice 94:2, 217-224

  222. 222

    Sen He, Xiaoping Chen, Kaijun Cui, Yong Peng, Kai Liu, Zhengbing Lv, Rui Yang, Xiaoyan Zhou. (2011) Validity evaluation of recently published diabetes risk scoring models in a general Chinese population. Diabetes Research and Clinical Practice

  223. 223

    Mohammad Zubair, Abida Malik, Jamal Ahmad. (2011) Incidence, risk factors for amputation among patients with diabetic foot ulcer in a North Indian tertiary care hospital. The Foot

  224. 224

    Horng-Yih Ou, Yi-Ching Yang, Hung-Tsung Wu, Jin-Shang Wu, Feng-Hwa Lu, Chih-Jen Chang. (2011) Serum fetuin-A concentrations are elevated in subjects with impaired glucose tolerance and newly diagnosed type 2 diabetes. Clinical Endocrinology 75:4, 450-455

  225. 225

    Juliana C.N. Chan, Siew Pheng Chan, Chaicharn Deerochanawong, Ruby T. Go, Kok-Onn Lee, Ronald Ching-Wan Ma, Chang-Yu Pan, Wayne H-H. Sheu, Philip Barter. (2011) Diabetic dyslipidaemia in Asian populations in the Western Pacific Region: What we know and don’t know. Diabetes Research and Clinical Practice 94:1, 1-13

  226. 226

    Weiping Jia. (2011) What have we learnt from genetic studies of type 2 diabetes in Chinese?. Journal of Diabetes Investigation 2:5, 331-332

  227. 227

    Zhi-Hua Feng, Yuan-Shan Wang, Yu-Guo Zheng. (2011) A new microtiter plate-based screening method for microorganisms producing Alpha-amylase inhibitors. Biotechnology and Bioprocess Engineering 16:5, 894-900

  228. 228

    Jian-jun Dong, Neng-jun Lou, Jia-jun Zhao, Zhong-wen Zhang, Lu-lu Qiu, Ying Zhou, Lin Liao. (2011) Evaluation of a risk factor scoring model in screening for undiagnosed diabetes in China population. Journal of Zhejiang University SCIENCE B 12:10, 846-852

  229. 229

    Yi-Ming Mu, Anoop Misra, John M.F. Adam, Siew Pheng Chan, Francis C.C. Chow, Elaine Cheeay Cunanan, Chaicharn Deerochanawong, Hak Chul Jang, Nguyen Thy Khue, Wayne H.-H. Sheu, Kevin E.K. Tan. (2011) Managing diabetes in Asia: Overcoming obstacles and the role of DPP-IV inhibitors. Diabetes Research and Clinical Practice

  230. 230

    Yan Wang, Xin Xin, Zhendong Jin, Yan Hu, Xianhui Li, Jianzhao Wu, Manwen Jin. (2011) Anti-diabetic effects of pentamethylquercetin in neonatally streptozotocin-induced diabetic rats. European Journal of Pharmacology 668:1-2, 347-353

  231. 231

    Dan-Tong Zhao, Hui-Yu Liao, Yan-Min Liu, Yan Zhao, Xia Feng, Hui-Ping Yan. (2011) Prognostic Factors and Survival Analysis of Antimitochondrial Antibody-Positive Primary Biliary Cirrhosis in Chinese Patients. Digestive Diseases and Sciences 56:9, 2750-2757

  232. 232

    Xin Mou, Wen-hong Liu, Dan-yang Zhou, Ying-hui Liu, Yong-bin Hu, Guo-ling Ma, Cheng-min Shou, Jia-wei Chen, Jin-xi Zhao. (2011) Association of Chinese medicine constitution susceptibility to diabetic nephropathy and transforming growth factor-β1 (T869C) gene polymorphism. Chinese Journal of Integrative Medicine 17:9, 680-684

  233. 233

    Shih-Tzer TSAI, Faruque PATHAN, Linong JI, Vincent Tok Fai YEUNG, Manoj CHADHA, Ketut SUASTIKA, Hyun Shik SON, Kevin Eng Kiat TAN, Yupin BENJASURATWONG, Thy Khue NGUYEN, Farrukh IQBAL. (2011) First insulinization with basal insulin in patients with Type 2 diabetes in a real-world setting in Asia. Journal of Diabetes 3:3, 208-216

  234. 234

    Hui Dong, Fu’er Lu, Nan Wang, Xin Zou, Jingjing Rao. (2011) Type 2 diabetic patients with non-alcoholic fatty liver disease exhibit significant haemorheological abnormalities. Frontiers of Medicine 5:3, 288-293

  235. 235

    Chunwei Ye, Xiaojuan Li, Yu Wang, Yuying Zhang, Mengyin Cai, Baoyi Zhu, Panwei Mu, Xuan Xia, Yi Zhao, Jianping Weng, Xin Gao, Xingqiao Wen. (2011) Diabetes causes multiple genetic alterations and downregulates expression of DNA repair genes in the prostate. Laboratory Investigation 91:9, 1363-1374

  236. 236

    L. Xu, W. M. Chan, Y. F. Hui, T. H. Lam. (2011) Association between HbA1c and cardiovascular disease mortality in older Hong Kong Chinese with diabetes. Diabetic Medicineno-no

  237. 237

    C. Pan, W. Yang, W. Jia, J. Weng, G. Liu, B. Luo, X. Li, Z. Fu, H. Tian. (2011) Psychological status of Chinese patients with Type 2 diabetes: data review of Diabcare-China studies. Diabetic Medicineno-no

  238. 238

    Qiaohui Qian, Xu Li, Bo Feng. (2011) Impact of hypertension, overall obesity and abdominal obesity on diabetes incidence in Shanghai residents with different glucose levels. Diabetes Research and Clinical Practice

  239. 239

    Chun-Ming Ma, Fu-Zai Yin, Rui Wang, Chun-Mei Qin, Bo Liu, Dong-Hui Lou, Qiang Lu. (2011) Glycemic Variability in Abdominally Obese Men With Normal Glucose Tolerance as Assessed by Continuous Glucose Monitoring System. Obesity 19:8, 1616-1622

  240. 240

    Henry Greenberg, Susan U. Raymond, Stephen R. Leeder. (2011) The Prevention of Global Chronic Disease: Academic Public Health's New Frontier. American Journal of Public Health 101:8, 1386-1390

  241. 241

    Dong-Ming Shen, Songnian Lin, Emma R Parmee. (2011) A survey of small molecule glucagon receptor antagonists from recent patents (2006 – 2010). Expert Opinion on Therapeutic Patents 21:8, 1211-1240

  242. 242

    Wan-Ling Lin, Wei-Wei Su, Xue-Ying Cai, Lv-Keng Luo, Pei-Bo Li, Yong-Gang Wang. (2011) Fermentation effects of oligosaccharides of Radix Ophiopogonis on alloxan-induced diabetes in mice. International Journal of Biological Macromolecules 49:2, 194-200

  243. 243

    Nikolaos Papanas, Aaron I. Vinik, Dan Ziegler. (2011) Neuropathy in prediabetes: does the clock start ticking early?. Nature Reviews Endocrinology 7:11, 682-690

  244. 244

    Chandrakant Ankolekar, Kalidas Shetty. Fermentation-Based Processing of Food Botanicals for Mobilization of Phenolic Phytochemicals for Type 2 Diabetes Management. In: Functional Foods, Nutraceuticals, and Degenerative Disease Prevention. Wiley-Blackwell, 2011:341-355.

  245. 245

    Tianjie Li, Xiaopan Wu, Xilin Zhu, Jingyun Li, Liping Pan, Pengtao Li, Zhenhui Xin, Ying Liu. (2011) Association analyses between the genetic polymorphisms of HNF4A and FOXO1 genes and Chinese Han patients with type 2 diabetes. Molecular and Cellular Biochemistry 353:1-2, 259-265

  246. 246

    Ping Zhu, Chuan Yang, Li-Hong Chen, Meng Ren, Guo-juan Lao, Li Yan. (2011) Impairment of human keratinocyte mobility and proliferation by advanced glycation end products-modified BSA. Archives of Dermatological Research 303:5, 339-350

  247. 247

    Nikolaos Papanas, Niki Katsiki, Apostolos I Hatzitolios, Efstratios Maltezos. (2011) Pioglitazone: a valuable component of combination therapy for type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy 12:10, 1457-1461

  248. 248

    Yoriko Heianza, Shigeko Hara, Yasuji Arase, Kazumi Saito, Kazuya Fujiwara, Hiroshi Tsuji, Satoru Kodama, Shiun Dong Hsieh, Yasumichi Mori, Hitoshi Shimano, Nobuhiro Yamada, Kinori Kosaka, Hirohito Sone. (2011) HbA1c 5·7–6·4% and impaired fasting plasma glucose for diagnosis of prediabetes and risk of progression to diabetes in Japan (TOPICS 3): a longitudinal cohort study. The Lancet 378:9786, 147-155

  249. 249

    J. B. Echouffo-Tcheugui, M. K. Ali, S. J. Griffin, K. M. V. Narayan. (2011) Screening for Type 2 Diabetes and Dysglycemia. Epidemiologic Reviews 33:1, 63-87

  250. 250

    George Dailey. (2011) Rapid-acting insulin glulisine: an update on clinical experience. Expert Review of Endocrinology & Metabolism 6:4, 527-542

  251. 251

    Xiang Li, Ting Xiao, Yuzhen Wang, Hongbin Gu, Zhiguo Liu, Yufeng Jiang, Yanjun Liu, Zuqian Lu, Xiaopin Yang, Yin Lan, Zhangrong Xu. (2011) Incidence, risk factors for amputation among patients with diabetic foot ulcer in a Chinese tertiary hospital. Diabetes Research and Clinical Practice 93:1, 26-30

  252. 252

    Xiao Yun Bao, Bin Peng, Mao Sheng Yang. (2011) Replication study of novel risk variants in six genes with type 2 diabetes and related quantitative traits in the Han Chinese lean individuals. Molecular Biology Reports

  253. 253

    Zhi-jia ZHANG, Shen QU. (2011) Na+-glucose cotransporter inhibitor for treatment of diabetes. Academic Journal of Second Military Medical University 31:4, 435-438

  254. 254

    Hong-Bo Ren, Tao Yu, Chao Liu, Yan-Qing Li. (2011) Diabetes mellitus and increased risk of biliary tract cancer: systematic review and meta-analysis. Cancer Causes & Control 22:6, 837-847

  255. 255

    Christian Herder, Michael Roden. (2011) Genetics of type 2 diabetes: pathophysiologic and clinical relevance. European Journal of Clinical Investigation 41:6, 679-692

  256. 256

    Wen-Yuan Lin, F. Xaiver Pi-Sunyer, Ching-Chu Chen, Lance E. Davidson, Chiu-Shong Liu, Tsai-Chung Li, Mei-Fong Wu, Chia-Ing Li, Walter Chen, Cheng-Chieh Lin. (2011) Coffee consumption is inversely associated with type 2 diabetes in Chinese. European Journal of Clinical Investigation 41:6, 659-666

  257. 257

    Fang Chai, Yong Wang, Yong Zhou, Yuan Liu, Donghua Geng, Jingang Liu. (2011) Adiponectin Downregulates Hyperglycemia and Reduces Pancreatic Islet Apoptosis After Roux-En-Y Gastric Bypass Surgery. Obesity Surgery 21:6, 768-773

  258. 258

    Paula H Palmer, Bin Xie, Liming Lee, Chih-Ping Chou, Ping Sun, Bree Hemingway, C. Anderson Johnson. (2011) The China Seven Cities Study (CSCS) consortium: adapting evidence-based prevention science from west to east. Translational Behavioral Medicine 1:2, 283-288

  259. 259

    Juliana C. N. Chan, Wingyee So, Ronald C. W. Ma, Peter C. Y. Tong, Rebecca Wong, Xilin Yang. (2011) The Complexity of Vascular and Non-Vascular Complications of Diabetes: The Hong Kong Diabetes Registry. Current Cardiovascular Risk Reports 5:3, 230-239

  260. 260

    Wayne H.-H. Sheu, Azhari Rosman, Ambrish Mithal, Namsik Chung, Yean Teng Lim, Chaicharn Deerochanawong, Pradana Soewondo, Moon-Kyu Lee, Kun-Ho Yoon, Oliver Schnell. (2011) Addressing the burden of type 2 diabetes and cardiovascular disease through the management of postprandial hyperglycaemia: An Asian-Pacific perspective and expert recommendations. Diabetes Research and Clinical Practice 92:3, 312-321

  261. 261

    Tony K T Lam. (2011) China needs to boost funding for graduate students to stay competitive. Nature Medicine 17:6, 655-655

  262. 262

    Yan-Hui Lu, Ju-Ming Lu, Shu-Yu Wang, Chun-Lin Li, Run-Ping Zheng, Hui Tian, Xian-Ling Wang. (2011) Outcome of intensive integrated intervention in participants with impaired glucose regulation in China. Advances in Therapy 28:6, 511-519

  263. 263

    Wing-Yee SO, Josephine RABOCA, Leorino SOBREPENA, Kun-Ho YOON, Chaicharn DEEROCHANAWONG, Low-Tone HO, Thep HIMATHONGKAM, Peter TONG, Greg LYUBOMIRSKY, Gary KO, Hairong NAN, Juliana CHAN, . (2011) Comprehensive risk assessments of diabetic patients from seven Asian countries: The Joint Asia Diabetes Evaluation (JADE) program*. Journal of Diabetes 3:2, 109-118

  264. 264

    F. Zhang, L. Dong, C.P. Zhang, B. Li, J. Wen, W. Gao, S. Sun, F. Lv, H. Tian, J. Tuomilehto, L. Qi, C. L. Zhang, Z. Yu, X. Yang, G. Hu. (2011) Increasing prevalence of gestational diabetes mellitus in Chinese women from 1999 to 2008. Diabetic Medicine 28:6, 652-657

  265. 265

    Xin Wang, Zhao Wang, Jiang Z. Liu, Jun X. Hu, Hong L. Chen, Wen L. Li, Chun X. Hai. (2011) Double antioxidant activities of rosiglitazone against high glucose-induced oxidative stress in hepatocyte. Toxicology in Vitro 25:4, 839-847

  266. 266

    Yue Qi, Jing Liu, Wei Wang, Miao Wang, Jia-yi Sun, Jun Liu, Yan Li, Zhao-su Wu, Dong Zhao. (2011) The HindIII polymorphism in the lipoprotein lipase gene predicts type 2 diabetes risk among Chinese adults. Clinica Chimica Acta 412:13-14, 1229-1233

  267. 267

    M. Uusitupa, J. Tuomilehto, P. Puska. (2011) Are we really active in the prevention of obesity and type 2 diabetes at the community level?. Nutrition, Metabolism and Cardiovascular Diseases 21:5, 380-389

  268. 268

    Baqiyyah Conway, Yong-Bing Xiang, Raquel Villegas, Xianglan Zhang, Honglan Li, Xiaoyan Wu, Gong Yang, Yu-Tang Gao, Wei Zhang, Xiao-Ou Shu. (2011) Hip Circumference and the Risk of Type 2 Diabetes in Middle-Aged and Elderly Men and Women: The Shanghai Women and Shanghai Men’s Health Studies. Annals of Epidemiology 21:5, 358-366

  269. 269

    C. M. Y. Lee, S. Colagiuri, M. Ezzati, M. Woodward. (2011) The burden of cardiovascular disease associated with high body mass index in the Asia-Pacific region. Obesity Reviews 12:5, e454-e459

  270. 270

    Zhaoxia Jia, Yong Zhou, Xiurong Liu, Yilong Wang, Xingquan Zhao, Yongjun Wang, Wannian Liang, Shouling Wu. (2011) Comparison of different anthropometric measures as predictors of diabetes incidence in a Chinese population. Diabetes Research and Clinical Practice 92:2, 265-271

  271. 271

    Tsung O. Cheng. (2011) Diabetes epidemic in China and its economic impact. International Journal of Cardiology 149:1, 1-3

  272. 272

    Min Liu, Changyu Pan, Mengmeng Jin. (2011) A Chinese Diabetes Risk Score for Screening of Undiagnosed Diabetes and Abnormal Glucose Tolerance. Diabetes Technology & Therapeutics 13:5, 501-507

  273. 273

    -Wei Du Hong, -Yue Li Jia, He Yao. (2011) Glycemic and blood pressure control in older patients with hypertension and diabetes: association with carotid atherosclerosis. Journal of Geriatric Cardiology 8:1, 24-30

  274. 274

    Xu-hong Hou, Yun-xia Zhu, Hui-juan Lu, Hui-fen Chen, Qiang Li, Shan Jiang, Kun-san Xiang, Wei-ping Jia. (2011) Non-alcoholic fatty liver disease's prevalence and impact on alanine aminotransferase associated with metabolic syndrome in the Chinese. Journal of Gastroenterology and Hepatology 26:4, 722-730

  275. 275

    Shao-Yuan Chuang, Wen-Ting Yeh, Yi-Lin Wu, Hsing-Yi Chang, Wen-Harn Pan, Chwen-Keng Tsao. (2011) Prediction equations and point system derived from large-scale health check-up data for estimating diabetic risk in the Chinese population of Taiwan. Diabetes Research and Clinical Practice 92:1, 128-136

  276. 276

    Stephen Colagiuri. (2011) Epidemiology of Prediabetes. Medical Clinics of North America 95:2, 299-307

  277. 277

    Yufeng Jiang, Sha Huang, Xiaobing Fu, Hongwei Liu, Xingwu Ran, Shuliang Lu, Dahai Hu, Qiang Li, Hongwei Zhang, Ying Li, Runxiu Wang, Ting Xie, Biao Cheng, Lingfeng Wang, Yi Liu, Xiangbai Ye, Chunmao Han, Huade Chen. (2011) Epidemiology of chronic cutaneous wounds in China. Wound Repair and Regeneration 19:2, 181-188

  278. 278

    Ranhua Jiang, Zhibo Han, Guangsheng Zhuo, Xiaodan Qu, Xue Li, Xin Wang, Yuankang Shao, Shimin Yang, Zhong Chao Han. (2011) Transplantation of placenta-derived mesenchymal stem cells in type 2 diabetes: a pilot study. Frontiers of Medicine 5:1, 94-100

  279. 279

    Zisun Kim, Kyung Yul Hur. (2011) Laparoscopic Mini-gastric Bypass for Type 2 Diabetes: The Preliminary Report. World Journal of Surgery 35:3, 631-636

  280. 280

    Yali Jing, Dalong Zhu, Yan Bi, Donghui Yang, Yun Hu, Shanmei Shen. (2011) Monocyte chemoattractant protein 1–2518 A/G polymorphism and susceptibility to type 2 diabetes in a Chinese population. Clinica Chimica Acta 412:5-6, 466-469

  281. 281

    Norman K. Hollenberg. (2011) Obesity and the Kidney. Current Hypertension Reports 13:1, 11-13

  282. 282

    Juliana CN Chan. (2011) What can we learn from the recent blood glucose lowering megatrials?. Journal of Diabetes Investigation 2:1, 1-5

  283. 283

    Y. M. K. Farag, M. R. Gaballa. (2011) Diabesity: an overview of a rising epidemic. Nephrology Dialysis Transplantation 26:1, 28-35

  284. 284

    Hongfu Zhong, Qionglin Liang, Jianfei Xia, Ping Hu, Yiming Wang, Xiaolin Tong, Guoan Luo. (2011) Simultaneous LC–UV–MS–MS Analysis of Nine Pivotal Metabolites in Human Serum: Application to Studies of Impaired Glucose Tolerance. Chromatographia 73:1-2, 149-155

  285. 285

    Jie Wu, Wen-hua Yan, Ling Qiu, Xin-qi Chen, Xiu-zhi Guo, Wei Wu, Liang-yu Xia, Xu-zhen Qin, Yan-hong Liu, Hai-tao Ding, Shao-mei Han, Cheng-li Xu, Guang-jin Zhu. (2011) High prevalence of coexisting prehypertension and prediabetes among healthy adults in northern and northeastern China. BMC Public Health 11:1, 794

  286. 286

    GA Thomson. (2011) Do current IDF predictions underestimate the true and future burden of diabetes?. Practical Diabetes International 28:1, 5-6

  287. 287

    Angela M Thompson, Yonghong Zhang, Weijun Tong, Tan Xu, Jing Chen, Li Zhao, Tanika N Kelly, Chung-Shiuan Chen, Lydia A Bazzano, Jiang He. (2011) Association of inflammation and endothelial dysfunction with metabolic syndrome, prediabetes and diabetes in adults from Inner Mongolia, China. BMC Endocrine Disorders 11:1, 16

  288. 288

    Irfan J. Lodhi, Xiaochao Wei, Clay F. Semenkovich. (2011) Lipoexpediency: de novo lipogenesis as a metabolic signal transmitter. Trends in Endocrinology & Metabolism 22:1, 1-8

  289. 289

    Salome A Rebello, Cynthia H Chen, Nasheen Naidoo, Wang Xu, Jeannette Lee, Kee Seng Chia, E Shyong Tai, Rob M van Dam. (2011) Coffee and tea consumption in relation to inflammation and basal glucose metabolism in a multi-ethnic Asian population: a cross-sectional study. Nutrition Journal 10:1, 61

  290. 290

    Jinjuan Peng, Haidong Zou, Weiwei Wang, Jiong Fu, Bingjie Shen, Xuelin Bai, Xun Xu, Xi Zhang. (2011) Implementation and first-year screening results of an ocular telehealth system for diabetic retinopathy in China. BMC Health Services Research 11:1, 250

  291. 291

    C. Mary Schooling, Chaoqiang Jiang, Weisen Zhang, Tai Hing Lam, Kar Keung Cheng, Gabriel M. Leung. (2011) Adolescent Build and Diabetes: The Guangzhou Biobank Cohort Study. Annals of Epidemiology 21:1, 61-66

  292. 292

    Amina Khambalia, Philayrath Phongsavan, Ben J Smith, Kieren Keke, Li Dan, Andrew Fitzhardinge, Adrian E Bauman. (2011) Prevalence and risk factors of diabetes and impaired fasting glucose in Nauru. BMC Public Health 11:1, 719

  293. 293

    Chaowei Fu, Yue Chen, Fadi Wang, Xuecai Wang, Jiangen Song, Qingwu Jiang. (2011) High prevalence of hyperglycaemia and the impact of high household income in transforming Rural China. BMC Public Health 11:1, 862

  294. 294

    Shu-Qiang Li, Yong Zhou, Yong Wang, Yuan Liu, Dong-Hua Geng, Jin-Gang Liu. (2011) Upregulation of IRS-1 Expression in Goto-Kakizaki Rats Following Roux-en-Y Gastric Bypass Surgery: Resolution of Type 2 Diabetes?. The Tohoku Journal of Experimental Medicine 225:3, 179-186

  295. 295

    Chun Wang, Huiwen Tan, Hongling Yu, Xiangxun Zhang, Lixia Suo, Zhiming Lu, Su Pu, Yerong Yu. (2011) Impairment of insulin action in non-obese, normal-glucose tolerant, first-degree relatives of Chinese type 2 diabetic patients. Diabetes Research and Clinical Practice 91:1, 67-71

  296. 296

    Wei-Lian Sun, Li-Li Chen, Su-Zhan Zhang, Yan-Min Wu, Yue-Zhong Ren, Guang-Ming Qin. (2011) Inflammatory Cytokines, Adiponectin, Insulin Resistance and Metabolic Control after Periodontal Intervention in Patients with Type 2 Diabetes and Chronic Periodontitis. Internal Medicine 50:15, 1569-1574

  297. 297

    Kyung Yul Hur, Zisun Kim. (2011) The surgical treatment for type 2 diabetes mellitus. Journal of the Korean Medical Association 54:2, 181

  298. 298

    David B. Sacks, Mark Arnold, George L. Bakris, David E. Bruns, Andrea Rita Horvath, M. Sue Kirkman, Ake Lernmark, Boyd E. Metzger, David M. Nathan. (2011) Executive Summary: Guidelines and Recommendations for Laboratory Analysis in the Diagnosis and Management of Diabetes Mellitus. Laboratory Medicine Online 1:4, 173

  299. 299

    Yun Gao, Xing-Wu Ran, Xiao-Hua Xie, Hua-Lin Lu, Tao Chen, Yan Ren, Yang Long, Hao-Ming Tian. (2011) Prevalence of overweight and obesity among Chinese Yi nationality: a cross-sectional study. BMC Public Health 11:1, 919

  300. 300

    David C.W. Lau. (2011) A World with Fewer People with Diabetes Noncommunicable Diseases. Canadian Journal of Diabetes 35:4, 314-316

  301. 301

    (2011) Titration of Insulin Glargine in Patients with Type 2 Diabetes Mellitus in Asia: Physician- Versus Patient-Led? Rationale of the Asian Treat to Target Lantus Study (ATLAS). Diabetes Technology & Therapeutics 13:1, 67-72

  302. 302

    Robert L. Rosenfield, Brian Bordini. (2010) Evidence that obesity and androgens have independent and opposing effects on gonadotropin production from puberty to maturity. Brain Research 1364, 186-197

  303. 303

    Tao Chen, Yan Ren, Yuanyuan Liu, Yang Long, Xiangxun Zhang, Hongling Yu, Jin Xu, Ting Yu, Haoming Tian. (2010) Serum gamma-glutamyl transferase, ferritin and the risk of type 2 diabetes in women from a Chinese minority. Diabetes Research and Clinical Practice 90:3, 352-357

  304. 304

    Yijun Zhou, Yan Li, Dan Zhang, Jiahe Wang, Hongwu Yang. (2010) Prevalence and predictors of osteopenia and osteoporosis in postmenopausal Chinese women with type 2 diabetes. Diabetes Research and Clinical Practice 90:3, 261-269

  305. 305

    Xuan XIA, Jianping WENG. (2010) Targeting metabolic syndrome: Candidate natural agents. Journal of Diabetes 2:4, 243-249

  306. 306

    Michele Cecchini, Franco Sassi, Jeremy A Lauer, Yong Y Lee, Veronica Guajardo-Barron, Daniel Chisholm. (2010) Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness. The Lancet 376:9754, 1775-1784

  307. 307

    Andrew Plump. (2010) Accelerating the pulse of cardiovascular R&D. Nature Reviews Drug Discovery 9:11, 823-824

  308. 308

    Jianping Weng, Yan Bi. (2010) Diabetes in China: The challenge now. Journal of Diabetes Investigation 1:5, 170-171

  309. 309

    Ming-wei Wang, Qing Liu, Cai-hong Zhou. (2010) Non-peptidic glucose-like peptide-1 receptor agonists: aftermath of a serendipitous discovery. Acta Pharmacologica Sinica 31:9, 1026-1030

  310. 310

    (2010) Journal of Diabetes NEWS. Journal of Diabetes 2:3, 130-135

  311. 311

    Public Health Aspects of Diabetes. In: Handbook of Diabetes. Wiley-Blackwell, 2010:16-21.

  312. 312

    (2010) Prevalence of Diabetes among Men and Women in China. New England Journal of Medicine 362:25, 2425-2426
    Free Full Text

  313. 313

    Louis CK Low. (2010) The epidemic of type 2 diabetes mellitus in the Asia-Pacific region. Pediatric Diabetes 11:4, 212-215

  314. 314

    (2010) Evolving R&D for emerging markets. Nature Reviews Drug Discovery 9:6, 417-420

  315. 315

    A.Y.Y. Fong, K.H. Sim. (2010) Picture my heart: Reflections on cardiovascular care in developing countries. CVD Prevention and Control 5:2, 63-64

  316. 316

    Felix Cheung. (2010) Public health: The sweet epidemic. Nature China

  317. 317

    J. Ren, Z. C. Pang, W. G. Gao, H. R. Nan, S. J. Wang, L. Zhang, Q. Qiao. (2010) C-Reactive Protein and Gamma-Glutamyltransferase Concentrations in Relation to the Prevalence of Type 2 Diabetes Diagnosed by Glucose or HbA1c Criteria in Chinese Adults in Qingdao, China. Experimental Diabetes Research 2010, 1-8

Letters

Trends

Most Viewed (Last Week)